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With the increasing demand for gender-affirming surgeries, it has become paramount for 92 
plastic and reconstructive surgeons to evaluate their techniques through assessment of clinical 93 
outcomes and patient satisfaction. Chest wall masculinization is the most commonly performed 94 
gender-affirming surgical intervention for transgender male and non-binary patients. The procedure 95 
has been cited to alleviate gender dysphoria, defined as the stress that results from the incongruence 96 
between one’s sex assigned at birth and one’s gender identity. Peri-areolar and double-incision 97 
mastectomy with free nipple grafts, are the most common techniques employed in chest 98 
masculinization surgery, but are limited by their relative inconsistency and inefficiency in 99 
reconstructing a natural anterior contour that comprehensively resembles that of a cis-masculine 100 
chest. The proposed “hockey stick” approach expands on the widely performed double-incision 101 
mastectomy to the axilla, with an additional step of revising the lateral chest wall folds of tissue 102 
excess. The central purpose of this study is to compare the “hockey stick” incision to existing 103 
reconstructive options, with respect to clinical outcomes and patient satisfaction. In addition, this 104 
review will discuss multiple challenges and considerations, with respect to validated survey 105 
instruments, access to care, healthcare disparities, legislative acts, insurance coverage, medical 106 
education, the Coronavirus pandemic, and evolving terminology, that may complicate the delivery 107 
of gender-affirming care. With such investigations and analyses, we hope to provide a valuable 108 
introduction and resource for healthcare providers, trainees, and medical students to refer to in the 109 
context of gender-affirming care. 110 
Patients who received chest masculinization surgery at Yale-New Haven Hospital were 111 
included in our analysis. A retrospective chart review, comprising demographic variables, 112 
procedural details, and post-operative events, was conducted. Selected modules from a validated 113 
survey instrument, the BODY-Q, were measured. Patients were classified by body mass index and 114 
incision, which included peri-areolar, inframammary fold, and “hockey stick” incision by date.  115 
 
27 of 73 (37.0%) participants completed the full survey and were included in the analysis. 116 
The “hockey stick” incision had comparable patient satisfaction and post-operative outcomes, 117 
compared to peri-areolar and double-incision mastectomy with free nipple graft techniques. Greater 118 
BMI patients had a higher incidence of wound dehiscence, compared to other weight 119 
classifications. 120 
The “hockey stick” incision is a readily performed, effective surgical technique for building 121 
a cis-masculine appearing chest in transgender men with efficient and predictable outcomes. While 122 
performed in patients with higher BMI, the “hockey stick” confers equivalent patients. Future 123 
outcomes should include a greater sample of patients.  124 
Gender-affirming surgery presents with promising opportunities to innovate new techniques 125 
and study clinical outcomes and patient satisfaction. Amidst such advancements, it is imperative to 126 
recognize the barriers in delivering gender-affirming care, to collaborate with other stakeholders, 127 
and together, strengthen efforts in medical education, policy, entrepreneurship, research, and 128 
advocacy for transgender and non-binary patients. There is great potential for plastic surgeons and 129 
their colleagues to lead the movement - to best serve the social and healthcare needs of such 130 
communities.  131 
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 1 
Specific Aims and Hypotheses  151 
Gender-affirming care has emerged as a modern frontier with medicine and healthcare. 152 
Adequate quality of such care often warrants the engagement of multiple professionals, who 153 
comprise a myriad of healthcare specialties, including mental health, primary care, endocrinology, 154 
urology, gynecology, and plastic and reconstructive surgery. Moreover, in this review, we will 155 
discuss multiple challenges and considerations, with respect to access to care, healthcare disparities, 156 
legislative acts, insurance coverage, medical education, and evolving terminology, that may 157 
complicate the delivery of gender-affirming care.  158 
The purpose of this thesis is multi-fold:  159 
A) Share relevant terminology and organizational resources to facilitate the discussion of 160 
gender, gender identity, and gender-affirming care  161 
B) Provide an overview of the stakeholders involved in providing gender-affirming care for 162 
transgender and non-binary patients  163 
C) Introduce chest masculinization surgery, the most commonly performed gender-affirming 164 
surgical intervention, and its role in alleviating gender dysphoria for transgender and non-165 
binary patients  166 
D) Consider the current state of validated survey instruments for assessing patient satisfaction 167 
from chest masculinization surgery  168 
E) Share the “hockey stick” technique, a refined approach towards chest masculinization 169 
surgery, and its adaptations for patients of different body habitus 170 
F) Compare the “hockey stick” technique to existing reconstructive options, including the 171 
peri-areolar mastectomy and the double-incision mastectomy with free nipple grafts 172 
(DMFNG), with respect to clinical outcomes and patient satisfaction  173 
G) Analyze the current insurance landscape for the provision of chest masculinization surgery, 174 
gaps in accessing gender-affirming care, and explanations for such challenges 175 
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H) Understand how the Coronavirus pandemic and current political environment have 176 
impacted gender affirming care and its provision  177 
I) Provide insights on how certain considerations within the field of gender-affirming surgery 178 
may challenge the foundational principles of plastic surgery and may jeopardize its 179 
classification as medically necessary 180 
J) Discuss the role of the private sector in designing gender-affirming care models and social 181 
media in building connections among patients 182 
K) Provide tangible recommendations regarding how plastic surgeons, trainees, and medical 183 
students may engage in gender-affirming outcomes research, educational opportunities, 184 
and larger advocacy efforts  185 
 186 
We hypothesize that the “hockey stick” incision is a safe and effective technique for building 187 
a cis-masculine appearing chest in transgender men with efficient and predictable outcomes. We 188 
additionally posit that the “hockey stick” confers equivalent patient satisfaction and clinical 189 
outcomes to peri-areolar and double-incision mastectomy. 190 
With such investigations and analyses, this review hopes to serve as a valuable introduction 191 
and resource for healthcare providers, trainees, and medical students to refer to in the context of 192 
gender-affirming care. Such discussions should not be construed as the opinions or beliefs of Yale 193 
University or the Yale University School of Medicine, but instead, should serve as a springboard 194 
for institutional engagement and collaboration for future educational and research endeavors.  195 
Introduction 196 
 197 
Gender Dysphoria and the World Professional Association for Transgender Health  198 
 199 
Gender dysphoria is a diagnosis that is defined by the discrepancy between an individual’s 200 
self-identified and natal gender (1). First described by Fisk and colleagues in 1974, the condition 201 
has been cited to uniquely impact approximately 1.3 percent of the United States population, many 202 
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of whom identity as transgender individuals (2-5). The criteria for a diagnosis of gender dysphoria 203 
are consistent with a six-month-long history of a strong desire to be emotionally and physically 204 
align with a gender that different other than one’s natal gender (2-5). Such incongruence with one’s 205 
gender identity and body may lead to profound physical distress and emotional distress, and 206 
ultimately, confer higher rates of psychiatric disorders, including anxiety, depression, and 207 
suicidality, sexual transmitted infections, and violence among such populations. Gender dysphoria 208 
can be alleviated through different measures, which may range from more conservative (i.e., cross 209 
dressing) to more invasive (i.e. hormonal or surgical intervention) (6). Such interventions have 210 
been shown to confer improved sense of self-confidence, safety, psychological well-being, and 211 
sexual satisfaction (2-5). Amidst the benefits, the treatment of gender dysphoria may present unique 212 
challenges for both patients and physicians, as transgender communities have historically faced 213 
healthcare disparities with regard to receiving delayed care, experiencing maltreatment from 214 
providers, and/or facing inadequate insurance coverage for certain procedures (7-12). Healthcare 215 
professionals, on the other hand, may not have received sufficient medical training to care for 216 
transgender and non-binary populations, and this lack of experience may preclude the delivery of 217 
high-quality healthcare to such patients (13-16).  218 
In order to best serve patients with gender dysphoria, the World Professional Association 219 
for Transgender Health (WPATH) was established in 1979. This 501(c) non-profit organization 220 
periodically issues international clinical protocols, known as Standards for Care (SOC), that 221 
outline the recommended assessment and treatment of transgender and gender non-conforming 222 
individuals who wish to undergo social, hormonal, or surgical transition (1). In addition, WPATH 223 
has taken the lead in updating and revising protocols to reflect the rapidly changing terminology in 224 
the realm of gender-affirming care. Furthermore, new terms have been introduced within clinical 225 
settings, the academic literature, and amongst the transgender and gender non-conforming 226 
communities. Definitions of the existing terms have changed over time. Such changes warrant an 227 
entity of multidisciplinary experts to ensure that healthcare professionals and the general public 228 
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utilize up-to-date and inclusive terminology – for the sake of ensuring the dignity, respect, and 229 
adequate healthcare for such communities.  230 
Table 1 includes a list of relevant terms from the Appendix of the WPATH SOC Version 231 
7 (2011) that will be discussed throughout this review (1). For example, transgender refers to 232 
“individuals who cross or transcend culturally- defined categories of gender,” while cis-gender 233 
refers to “an individual whose gender identity is congruent with their assigned sex.” Of note, an 234 





















Table 1. Relevant Terms from WPATH SOC Version 7 Appendix  255 
Term Definition 
Gender identity A person’s intrinsic sense of being male (a boy or a man), female (a girl or woman), or an 
alternative gender (e.g., boygirl, girlboy, transgender, genderqueer, eunuch).  
Sex Sex is assigned at birth as male or female, usually based on the appearance of the external 
genitalia. When the external genitalia are ambiguous, other components of sex (internal 
genitalia, chromosomal and hormonal sex) are considered in order to assign sex  
Gender role or 
expression 
Characteristics in personality, appearance, and behavior that in a given culture and historical 
period are designated as masculine or feminine (that is, more typical of the male or female social 
role). While most individuals present socially in clearly male or female gender roles, some 
people present in an alternative gender role such as genderqueer or specifically transgender. All 
people tend to incorporate both masculine and feminine characteristics in their gender 
expression in varying ways and to varying degrees. 
Gender dysphoria Distress that is caused by a discrepancy between a person’s gender identity and that person’s sex 




Formal diagnosis set forth by the Diagnostic Statistical Manual of Mental Disorders, 4th 
Edition, Text Rev (DSM IV-TR). Gender identity disorder is characterized by a strong and 
persistent cross-gender identification and a persistent discomfort with one’s sex or sense of 
inappropriateness in the gender role of that sex, causing clinically significant distress or 
impairment in social, occupational, or other important areas of functioning. 
Gender 
nonconforming 
Adjective to describe individuals whose gender identity, role, or expression differs from what is 
normative for their assigned sex in a given culture and historical period. 
 
Genderqueer Identity label that may be used by individuals whose gender identity and/or role does not 
conform to a binary understanding of gender as limited to the categories of man or woman, male 
or female 
Transgender Adjective to describe a diverse group of individuals who cross or transcend culturally- defined 
categories of gender. The gender identity of transgender people differs to varying degrees from 
the sex they were assigned at birth. 
Transsexual Adjective (often applied by the medical profession) to describe individuals who seek to change 
or who have changed their primary and/or secondary sex characteristics through femininizing or 
masculinizing medical interventions (hormones and/or surgery), typically accompanied by a 
permanent change in gender role. 
Cis-gender Individual whose gender identity is congruent with their assigned sex 
Transition Period of time when individuals change from the gender role associated with their sex assigned 
at birth to a different gender role. For many people, this involves learning how to live socially in 
“the other” gender role; for others this means finding a gender role and expression that is most 
comfortable for them. Transition may or may not include feminization or masculinization of the 
body through hormones or other medical procedures. The nature and duration of transition is 




Adjective to describe individuals assigned female at birth who are changing or who have 





Adjective to describe individuals assigned male at birth who are changing or who have changed 




Surgery to change primary and/or secondary sex characteristics to affirm a person’s gender 
identity. Sex reassignment surgery can be an important part of medically necessary treatment to 
alleviate gender dysphoria. 
 6 
Overview of Gender-Affirming Services Available for Transgender Patients  256 
Addressing gender dysphoria is of paramount importance for healthcare professionals, and 257 
often warrants a multi-disciplinary approach that involves mental health services, primary care, 258 
social work, diversity and inclusion, endocrinology, plastic and reconstructive surgery, and/or 259 
urology (6). Consultations and office appointments with such experts may assist healthcare 260 
providers in building rapport with such patients, and ultimately, achieving a stronger understanding 261 
a patient’s personal experience with gender dysphoria. Providers may delve into nuanced topics of 262 
gender identity, personal and cultural interpretations of gender or lack thereof, sexuality, 263 
employment, anticipated recovery duration, perception of one’s self and personal satisfaction, and 264 
finally, perception from the general public, when determining the appropriate course of treatment 265 
(17-19). Gender-affirming medical and/or surgical procedures, of course, are informed by a 266 
physical assessment to determine whether co-morbidities need to be addressed or general health, 267 
optimized, before any intervention. The following health care services will now be discussed: 268 
mental health, hormonal therapies (endocrinology), gender-affirming procedures to surgically 269 
modify one’s body to align gender identity with body image.  270 
Mental Health 271 
Mental health professionals have a pivotal role in the evaluation and diagnosis of 272 
professionals with gender dysphoria. Furthermore, mental health professionals, such as 273 
psychologists or psychiatrists, assess for pre-existing psychiatric conditions which might impact 274 
their patients’ candidacy for medical or surgical therapies (6). In addition, they must determine 275 
whether patients’ support system will be adequate during the process of transition. Of note, mental 276 
health assessment is not synonymous with psychotherapy. While many patients with gender 277 
dysphoria may benefit from psychotherapy, this is not a requirement for further medical or surgical 278 
intervention. Mental health professionals often write referral letters to surgeons on behalf of their 279 
patients who qualify for gender-affirming surgery. As denoted by the SOC, the content of the 280 
referral letter should include the following: general identifying characteristics, result of 281 
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psychosocial assessment, duration of relationship between mental health professional and patient, 282 
including an overview of previous evaluations, therapies, or counseling, explanation that the criteria 283 
for surgery have been met, including the clinical rationale for surgery, informed consent, and 284 
finally, a statement that the mental health professional is available for coordination of care after 285 
such interventions (1).   286 
Endocrinology 287 
Feminizing or masculinizing hormonal therapy may have a profound impact on the 288 
development of secondary sexual characteristics and psychosocial well-being for transgender 289 
patients. Some patients may refer to dubious sources or self-medicate in order to achieve a physical 290 
appearance that resembles that of the opposite gender. Endocrinologists play a vital role in ensuring 291 
that patients receive the appropriate doses for such hormonal regimens. For trans men, testosterone 292 
can have dramatic effects, with respect to increases in facial and body hair, male pattern baldness, 293 
increased muscle mass, male fat distribution, acne, cessation of menses, and deepening of the voice 294 
(6). For trans women, anti-androgenic medications, such as spironolactone, are impact to oppose 295 
the effects of testosterone. In addition, oral, intramuscular, and topical estrogen can be administered 296 
in order to promote feminizing features, such as female fat redistribution, breast growth, thinning 297 
of body and facial hair, as well as decreases in testicular volume, libido, and male pattern baldness. 298 
Patients often require a minimum of one year of cross-sex hormonal treatment in order to qualify 299 
for gender-affirming surgical procedures (1).  300 
Primary Care 301 
Primary care physicians (PCPs) are involved in all aspects of care for transgender 302 
individuals. Moreover, they are often involved in prescribing and/or titrating hormone therapy for 303 
patients. They may diagnose conditions that present at higher rates within transgender populations, 304 
such as mental illness or sexually transmitted infections. PCPs serve as the gateway that determine 305 
whether their transgender patients are medically fit in order to obtain gender-affirming surgical 306 
procedures, if appropriate. Finally, they have the responsibility to provide the appropriate screening 307 
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for breast, cervical, and prostate cancers, and must consider the remnants of such tissues even after 308 
surgical removal. As the mediator between mental health, endocrinology, and surgical services, 309 
PCPs are significant in ensuring proper coordination of care, and have immense impact in 310 
promoting the psychological, social, and physical wellbeing of their transgender patients.  311 
Surgical Interventions 312 
For some patients, it may be determined that surgical interventions are best suited to 313 
alleviate discomfort and burden associated with gender dysphoria (2-6, 20-22). Surgical plans are 314 
tailored to each individual patient, and involve discussion of not only anatomic considerations, but 315 
also patient-specific factors, which may include gender identity, personal and cultural 316 
interpretations of masculinity, femininity, sexuality, employment, anticipated recovery duration, 317 
insurance coverage, perception of one’s self and personal satisfaction, and finally, potential 318 
perception from the general public, when determining the appropriate reconstruction (17-19). 319 
Plastic surgeons have emerged as the main surgical providers for transgender patients, performing 320 
a variety of procedures for masculinization and feminization of certain body characteristics. There 321 
are a number of complexities and considerations, however, that plastic surgeons often implement 322 
upon initial consultation through the post-operative recovery process in order to best care for 323 
transgender patients. These will be discussed in future sections. Non-binary and gender non-324 
conforming patients may or may not benefit from surgical interventions, and typical procedures 325 
may be revised in order to perform the appropriate reconstruction that aligns one’s gender identity 326 
and physical appearance. It should be stated that not every patient necessarily wants, requires, or 327 
qualifies for such procedures.  328 
Figures 1A and 1B denote the currently available surgical procedures that may be 329 
performed for transgender women (Male-to-Female) and transgender men (Female-to-Male) (6). 330 
Of note, gender non-conforming individuals may receive any masculinize or feminine spectrum 331 
procedures, such as chest surgery and body contouring. This communication will focus on chest 332 
 9 
masculinization surgery, or “top surgery,” the most common gender-affirming procedure 333 
performed to date.  334 
Figure 1. Overview of Surgeries Offered for A) Transgender Women (Male to Female); 335 
B) Transgender Men (Female to Male)  336 
 337 
Overview of Chest Masculinization Surgery, Standard Techniques, and the “Hockey 338 
Stick Incision” 339 
 340 
Chest masculinization surgery, or “top surgery,” is performed for transmasculine (those 341 
assigned female at birth who identify as male/masculine) and non-binary (those who may 342 
experience a gender identity that is neither exclusively male or female) patients (20). The ultimate 343 
goal of chest masculinization surgery is to alleviate gender dysphoria and achieve gender 344 
congruence (21-28). In doing so, an improved sense of self-confidence, safety, psychological well-345 
being, and sexual satisfaction may be achieved. These considerations are addressed through several 346 
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mechanisms: 1) removal of breast tissue and excess skin, 2) appropriate reduction in size and 347 
placement of the nipple-areolar complex to a more typical masculine position, 3) elimination or 348 
diminishment of the inframammary fold, 4) minimization of anterolateral chest skin/fat folds, and 349 
5) low complication/revision rates and efficiency of the procedure. (20-28) While the appropriate 350 
reconstruction details vary among individual patients, chest masculinization surgery is performed 351 
in order to achieve an aesthetic result that resembles a cis-masculine chest. It is important to note, 352 
however, that the concept of binary gender and any assumed transmasculine aspiration of cis-353 
normalcy is problematic for some. Thus, these specific considerations should be explored in future 354 
investigations, as well as within the context of each pre-operative patient-surgeon discussion of 355 
surgical options and expectations, risks and benefits, and informed consent. 356 
Several techniques, including those utilized for gynecomastia, aesthetic mastopexy, and 357 
breast reduction, have been widely adapted for chest masculinization surgery. These approaches 358 
include the semicircular peri-areolar, otherwise known as the “keyhole mastectomy,” mastectomy 359 
with peri-areolar skin excision, trans-areolar, concentric circular extended concentric circular, and 360 
inferior pedicle tunnelized nipple-areolar complex (NAC) (20). Choice of technique principally 361 
depends on patient-specific characteristics, which include overall body habitus, position of the 362 
NAC, breast volume, skin envelope, grade of ptosis, and skin elasticity (20-28). 363 
Two of the most common techniques for chest masculinization surgery include the peri-364 
areolar mastectomy and the double-incision mastectomy with free nipple grafts (DMFNG) (Figure 365 
2) (29). The peri-areolar mastectomy is most appropriate for patients who have minimal excess 366 
breast volume, and skin, and good skin elasticity (i.e. few or no stretch marks in the breast region) 367 
(20-28). Advantages of this procedure include a small, well-concealed scar. However, this 368 
technique carries the risk for surgical site complications (i.e. hematoma, scar revision, seroma) and 369 
breast ptosis requiring repeat intervention. In contrast, the DMFNG is the most common surgical 370 
option in patients with larger pre-operative breast mass. This particular technique provides 371 
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excellent exposure, optimization of the NAC position, low revision rates, and high patient 372 
satisfaction. However, it is associated with heavier scar burden, and often includes lateral chest 373 
wall scars and visibility or retained folds of skin, breast tissue and fat, which may require further 374 
time occupying revision procedures (20-28) (Table 2).  375 
 376 
Figure 2. Peri-areolar and IMF incisions  377 
 378 
Despite the widespread utilization of the DMFNG and peri-areolar incisions for chest 379 
masculinization, these techniques are limited by their relative inconsistency and inefficiency in 380 
reconstructing a natural anterior contour that comprehensively resembles that of a cis-masculine 381 
chest. The “hockey stick” technique expands on the widely performed double-incision mastectomy 382 
to the axilla, with an additional step of revising lateral chest wall folds of tissue excess (Table 2). 383 
In addition, the lengthening of the lateral inframammary fold (IMF) incision into areas of greater 384 
scar visibility has been described to address puckering or tethering at the lateral chest wall soft 385 
tissue (30-33). This technique is scalable to the degree of pre-operative excess tissue on the anterior 386 
and lateral chest wall, and ultimately allows for a more natural appearing chest contour that 387 
resembles that of a cis-male.  388 
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Table 2. Comparative advantages and disadvantages of various incision types for chest 389 
masculinization surgery 390 
 391 
Operative Technique – “Hockey Stick” Approach   392 
The “hockey stick” technique for chest masculinization was developed by Dr. John 393 
Persing, Section Chief of Plastic and Reconstructive Surgery at Yale University. This approach 394 
strives to achieve an aesthetic result that appears typically masculine through re-definition of the 395 
pectoralis major muscle, and is reserved for patients with a large amount of breast volume (as 396 
opposed to the peri-areolar incision utilized for patients with minimal breast volume). This review 397 
will assess surgical outcomes, as well as patient satisfaction, associated with this approach and 398 
compare these results with the current standard of care for chest masculinization (peri-areolar and 399 
DMFNG techniques). The operative technique is detailed below:  400 
Hockey stick incision extending into the axilla 401 
Pre-operative markings are performed in Video 1. A step-by-step illustration of the 402 

















Figure 3. Simple drawing depicting key steps of the hockey stick procedure  419 
 The “hockey stick” incision consists of two horizontal incisions, one at the IMF 420 
(horizontalized medially), and the other at the overlapping of the superior horizontal incision line 421 
above the upper limit of the NAC (Video 2).  422 
 423 
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Video 2. Intraoperative technique  424 
 425 
The superior breast incision is curvilinear and longer than the IMF incision, accounting for 426 
the additional skin overlying the breast tissue mound. The lateral limits are along the lateral border 427 
of the pectoralis muscle border the IMF and the anterior axillary line. The incision line is marked 428 
as an oblique line, just posterior, (1 cm) to the lateral border of the pectoralis muscle, and an antero-429 
posterior transverse plane approximately 2 centimeters (cm), inferior to the axillary crease.  The 430 
transverse incision line length in the axillary skin in a moderate-sized breast and body habitus, is 431 
approximately 7 cm antero-posteriorly. Importantly, this dimension is also defined on the posterior 432 
vertical-oblique oriented limb incision in the lateral chest wall. This line is defined by the most 433 
posterior point of the transverse incision in the axilla to its intersection with the IMF and the inferior 434 
extent of the anterior axillary line which runs along posterior border of the pectoralis muscle until 435 
the IMF. (Note: The adjustable 7 cm incision line is based on patient body habitus. In patients with 436 
greater BMI, the incision may be extended to 8-9 cms, while those with lesser BMI without folding 437 
of lateral chest wall tissue may not even require resection at the transverse axillary level.  This 438 
dimension will be consistently referred to as “7cm” hereafter for clarity.) This technique also allows 439 
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for reduction of any excess tissue along the lateral chest wall to include the tail of Spence (Figure 440 
4).  441 
Figure 4. Re-approximating the axilla using the 7cm markings  442 
     A                        B 443 
For orientation, the head is positioned toward the upper right of the images while the feet are at the bottom left. The 444 
images depict the axillary component of the “hockey stick” incision. 4a. A represents the point at which the pectoralis 445 
meets the anterior axillary line. B represents the pivot point around which the inferior and superior flaps will be joined. 446 
C represents a point 7cm from B. 4b. Point C is brought to meet A. This pulls the lateral chest wall upward, which 447 
tightens the lateral chest wall. 448 
 449 
The inferior incision in this technique is continued slightly more medially compared to the 450 
traditional inframammary fold incision and is flattened horizontally to further add greater symmetry 451 
in this now more visible aspect of the chest wall. But importantly, it is not joined directly to the 452 
contralateral breast IMF.  The superior breast incision is carried out largely in a horizontal plane at 453 
the level of the overlap of the areola with the IMF centrally, while the breast is pulled inferiorly 454 
under tension. The margins of the incision line taper off medially and laterally, as described earlier. 455 
As a result of the convex breast contour superiorly, the length of the superior incision line ultimately 456 
exceeds that of the inferior IMF incision line. To address this length discrepancy, the midline of 457 
the clavicle (which is marked at the beginning of surgery on the superior flap as a reference line) 458 
is advanced laterally during closure, such that the midline of the superior line joins the inferior 459 
midline (about 2 -2.5 cm further laterally) to account for the excess length imposed as a result of 460 
the convexity of the breast mound incision line (Figure 5).  The lateral chest wall skin excess will 461 
be discarded later as overlap tissue along the lateral pectoralis muscle border.  462 
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                              Figure 5. Shifting of the midline of the superior incision  463 
 464 
The blue dotted lines represent the midclavicular line marked at the beginning 
of surgery. In closing the incision, the point at the midclavicular line on the 
superior flap is reconnected to the inferior flap about 2cm lateral to the 
midclavicular line. Because of the contour of the breast, the inferior incision 
is shorter in length than the superior incision, and this shift reduces the length 
discrepancy of excess that remains on the superior  flap.  
 
 465 
In re-approximating the axillary incision line, a point 7cm inferior from the posterior- most 466 
corner of the horizontal axillary incision line is rotated to the junction of the anterior most point of 467 
the horizontal incision line at the anterior axillary line (Figure 4). This flattens the redundancy of 468 
the lateral chest excess tissue seen in most patients to some degree with a BMI greater than 20. 469 
Moreover, this technique places the scar line only at the posterior border of the pectoralis muscle, 470 
from the IMF to the axilla. 471 
Adjustments by BMI  472 
The “hockey stick” incision allows for fine tuning adjustments, both vertically and 473 
horizontally, based on BMI (performed in the pre-operative assessment of skin and fat excess.)  In 474 
patients with low BMI and limited breast ptosis, the “hockey stick” incision can be modified to 0 475 
to 6 cm. Liposuction is routinely done in the lateral chest wall fat and Tail of Spence, after the 476 
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mastectomy and realignment of the superior and inferior horizontal chest incision lines, but before 477 
final cutting of the skin overlap. In patients with high BMI, with large folds of lateral chest wall 478 
breast, adipose, and skin, the incision can be lengthened beyond 7 cm up to approximately 8-9 cm. 479 
An additional benefit of this unambiguous resection amount, is to achieve better symmetry given 480 
when two surgeons are simultaneously operating, one on each side.  481 
Natural chest ptosis 482 
Patients with higher BMI may seek an aesthetic outcome that favors a slight natural fold 483 
of the superior flap approximating the inferior border of the pectoralis muscle so as to accentuate 484 
the prominence of the muscle fold, and to be consistent with contour thickness of the upper and 485 
mid torso. Inadvertent thinning of the fatty tissue of the inferior end of the superior chest flap may 486 
result in a completely flat chest inconsistent with the remainder of the chest and upper abdomen. 487 
This initial dissection plane is done by first dissecting the superior flap at the IMF down to 488 
the underlying pectoralis fascia.  The incision line above the NAC is at a 45o angle until 489 
approximately 5-7cm below the clavicle.  490 
Nipple graft placement 491 
Compared to the nipple size, prominence, and position associated with feminine breasts, nipples 492 
on cis-male chests are typically smaller, have less projection, and are located more laterally and 493 
superiorly. Anatomic studies have demonstrated the diameter of cis-male nipples to be between 2.0 494 
and 2.8cm (34-36). To account for this, the nipple grafts are harvested using a 25mm cookie-cutter 495 
at the start of surgery. The grafts are later de-fatted with scissors at the back table. De-fatting the 496 
graft decreases projection while also increasing graft viability. The nipple position is determined 497 
lateral to the midline around the 4th-5th intercostal space, at a point approximately 2.5cm above the 498 
incision and 2.5cm lateral to the inferior horizontal IMF midline (33-35). This site of the nipple 499 
graft approximates the usual position of a male nipple when seated and in an upright position. Of 500 
note, the FNG protocol is identical among patients who receive the traditional IMF incision and the 501 
hockey stick incision.  502 
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 503 
The pre- and post-operative photographs are portrayed in Figure 6.  504 
Figure 6. Pre- and post-op photos of a patient who underwent the hockey stick procedure 505 
	506 
Pre- and post-op photographs of a patient with BMI 26.55. a, b, and c demonstrate pre-op photos from the front, lateral, 507 
and 45 degrees lateral view, respectively. d shows the final result at 2 months from the anterior view. e shows 508 
demonstrates axillary extension which is hidden in the axillary crease. f shows a 2-week post-op photo from the 45 509 
degrees lateral view, where the outline of the pectoralis muscle by the incision line can be appreciated.  510 
 511 
Patient Reported Outcome Measures in Chest Masculinization Surgery 512 
As chest masculinization surgery gains popularity among the transgender and non-binary 513 
populations, it is vital to assess clinical outcomes and patient reported satisfaction. All caregivers 514 
at some point need to refer to the academic literature in order to adapt and improve their treatment 515 
approaches. This is important in surgery, as maneuvers are often adopted or rejected based on 516 
review and critical analysis. Benefit from clarification of what factors lead to favorable clinical 517 
outcomes and which do not could result in a greater support of resolution of gender dysphoria.  518 
When surgical procedures are performed well, patients may feel empowered to share their 519 
experiences, and as a result, help educate peers who are considering chest masculinization surgery. 520 
Insurance providers often refer to cost savings, patient reported satisfaction, and clinical outcomes 521 
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when determining the extent of coverage in chest masculinization surgery (37). These collective 522 
perspectives relay the importance of assessing patient satisfaction and experience with chest 523 
masculinization surgery.  524 
Nonetheless, there has been a notable lag in developing validated, patient-reported instruments 525 
to evaluate its impact on patient wellbeing. Researchers have modified survey instruments, such as 526 
the BREAST-Q, TRANS-Q, and Body Uneasiness Test, that have been designed for cis-gender 527 
breast reconstruction (38-48). Such tools and their descriptions are summarized in Table 3.  528 
Table 3. Summary of Survey Instruments Used to Study Outcomes after Chest Masculinization 529 
Surgery 530 
Survey 
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While these resources may assess transgender patient outcomes, they have not been validated 534 
for chest masculinization surgery and gender dysphoria. Moreover, the Transgender Congruence 535 
Scale, Body Image Scale for Transexuals, and BODY-Q, are validated survey tools for transgender 536 
patients undergoing chest masculinization surgery. Moreover, the BODY-Q has documented higher 537 
levels of satisfaction with the appearance of both the chest and nipples, when compared from pre-538 
operative to post-operative timepoints, for chest masculinization surgery in transgender patients 539 
(49). Of note, however, the BODY-Q has limitations with respect to assessing satisfaction, 540 
particularly with respect to the appraisal of contouring scars. Scarring is widely assumed as 541 
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negative and potentially disfiguring among plastic surgeons, but may be viewed as a marker of 542 
identity, and as a result, may perceive a negative perception of scarring as hurtful and dismissive 543 
of their journey. Amidst its limitations, the BODY-Q has emerged as a promising instrument to 544 
survey transgender individuals who undergo chest masculinization, and will be discussed in this 545 
investigation. Of note, there have been international collaborative efforts to establish the GENDER-546 
Q, a series of modules that assesses outcomes after gender-affirming surgeries, such as chest 547 
masculinization and feminization (50). This survey instrument will be fundamental to the future 548 
evaluation of post-operative outcomes for transgender and non-binary patients.  549 
Methods 550 
Clinical and patient-reported outcomes were assessed through a retrospective chart review 551 
and BODY-Q (Memorial Sloan Kettering, New York, NY), a validated survey instrument that had 552 
been previously developed in order to assess patient satisfaction from body contouring or weight 553 
loss surgery (49,51-53). The survey tool has been formally validated for transgender men 554 
undergoing chest masculinization surgery (49,51-53).  555 
Retrospective Chart Review 556 
Following approval from the Yale University Institutional Review Board 557 
(HIC#2000022992), a retrospective chart review of transgender male patients who underwent chest 558 
masculinization by two Yale Medicine Plastic and Reconstructive surgeons (M.A. and J.P.)  559 
between May 2016 and August 2020 was conducted. These patients were classified into four 560 
cohorts, guided by incision type and time of surgery: 1) peri-areolar, 2) inframammary fold 561 
incision, 3) “hockey stick” incision (performed before July 2019), and 4) “hockey stick” incision 562 
(performed after July 2019). Delineation of date of surgery (July 2019) was performed to address 563 
the senior author’s progressive refinement of the “hockey stick” technique over time. Demographic 564 
variables such as age, body mass index (BMI), race, insurance status, ASA class, comorbidities, 565 
and smoking status were collected. In order to assess potential influence in post-operative events 566 
as well as to examine any notable trends among our patient population, complications, re-567 
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admissions, and re-operations, were also assessed. Furthermore, patients were stratified by BMI, 568 
as normal weight (BMI<25), overweight (BMI between 25-30), and obese (BMI>30) groups (54). 569 
Procedural details were summarized, including volume of liposuction, breast tissue removed, and 570 
perioperative complications. Complications considered include deep venous thrombosis (DVT), 571 
hematoma, seroma, infection, fat necrosis, nipple necrosis, readmission within 30 days, 572 
readmission within 90 days, relevant Emergency Department (ED) visits post-surgery, and re-573 
operation. 574 
Survey Design and Development  575 
Selected modules from the BODY-Q were used to assess appearance, quality of care, and 576 
experience of care. Only postoperative patients’ data were included. Survey responses were 577 
classified by the aforementioned cohorts.  The included modules are detailed (Table 4). 578 
Table 4. Descriptions of various BODY-Q modules distributed to patients  579 
 580 
Survey Distribution 581 
The survey was distributed via email through the Health Insurance Portability and 582 
Accountability Act (HIPAA) of 1996-compliant Qualtrics Software (Qualtrics, LLC, Provo, Utah). 583 
Patients were called in advance before the survey was sent to them in order to share the goals of 584 
the research investigation. Responses were collected over a one-month timeframe. Participation 585 
was voluntary and respondents did not receive any form of compensation for survey completion.  586 
Statistical analysis was conducted utilizing chi-square tests to compare categorical data 587 
between groups (SPSS, v.25.0, IBM Corp., Armonk, NY). Continuous data was analyzed via one-588 
way ANOVA for parametric data, and Kruskal-Wallis with Monte Carlo estimate for non-589 
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parametric data. Welch’s ANOVA was used for data in which there was unequal homogeneity of 590 
variances between groups, as determined by Levene’s test. Post-hoc analysis of significant findings 591 
with ANOVA was completed with Bonferroni, and for Welch’s ANOVA with Dunnett’s T3 test. 592 
Statistical significance was set at p ≤ 0.05. 593 
Student Contributions 594 
S.K., J.S., X.L., M.A., and J.P. conceived and designed the study. X.L., M.A., and J.P. 595 
provided administrative support. M.A. and J.P. provided the necessary study materials and patients 596 
for analysis. S.K. oversaw and led the collection and assembly of data, and was assisted by A.J., 597 
and M.M.  J.D. performed statistical analyses and worked with S.K. to interpret the data and initially 598 
present to the team. S.K., A.J., X.L., and A.S. contributed in the filming and video-editing for the 599 
included footage. S.K. and A.J. contributed to the writing of the manuscript, designing the figures, 600 
and organizing tables. J.S., X.L., M.A., and J.P. gave final approval for submission.  601 
Human Subjects Research 602 
 603 
All related research activities (i.e. survey distribution, retrospective chart review) were performed 604 
upon approval from the Yale Institutional Review Board (HIC# 2000022992) and adhered to all 605 
guidelines.  606 
Results 607 
Of the 73 patients in the total cohort, 39 (53.4%) responded to the survey (55). Among the 608 
respondents, four declined to answer questions, while eight only partially completed the survey. 609 
Therefore, 27 (37.0%) individuals provided complete data and were included in the final analysis.  610 
Chart Review 611 
There was no statistically significant difference among the four cohorts in terms of demographic 612 





Table 5. Demographic variables of all patients undergoing chest masculinization surgery 617 
 618 





Hockey Stick  
before 7/2019 
(n=11) 
Hockey Stick  
after 7/2019 
(n=4) p 
Age 18.8 ± 1.7 
25.8 ± 9.7 26.6 ± 9.3 21.8 ± 3.6 0.041** 
BMI  20.2 ± 2.4 
32.1 ± 5.3 30.1 ± 5.9 36.4 ± 5.5 <0.001** 
BMI Categorical  
   0.002** 
 Normal Weight 6 (100%) 1 (16.7%) 3 (27.3%) 0 (0.0%)  
 Overweight 0 (0.0%) 1 (16.7%) 2 (18.2%) 0 (0.0%)  
 Obese 0 (0.0%) 4 (66.7%) 6 (54.5%) 4 (100%)  
Ethnicity      1.000 
 Caucasian 5 (83.3%) 5 (83.3%) 7 (63.6%) 3 (75.0%)  
 Hispanic 1 (16.7%) 1 (16.7%) 2 (18.2%) 1 (25.0%)  
 African American 0 (0.0%) 0 (0.0%) 1 (9.1%) 0 (0.0%)  
 Asian 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Native American 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Other 0 (0.0%) 0 (0.0%) 1 (9.1%) 0 (0.0%)  
Insurance Type     0.681 
 Private 4 (66.7%) 1 (16.7%) 4 (36.4%) 2 (50.0%)  
 Medicaid 2 (33.3%) 4 (66.7%) 5 (45.5%) 2 (50.0%)  
 Medicare 0 (0.0%) 1 (16.7%) 2 (18.2%) 0 (0.0%)  
 Self-Pay  0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 None 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Unknown  0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
Co-Morbidities      
 Diabetes 0 (0.0%) 0 (0.0%) 1 (9.1%) 0 (0.0%) 1.000 
 Pre-Diabetes 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1.000 
 Hypertension 0 (0.0%) 1 (16.7%) 1 (9.1%) 0 (0.0%) 1.000 
 Mental Illness 2 (33.3%) 3 (50.0%) 9 (81.8%) 2 (50.0%) 0.214 
Substance Use      
 Cigarette Smoking 2 (33.3%) 0 (0.0%) 4 (36.4%) 1 (25.0%) 0.482 
 Smokeless Tobacco 1 (16.7%) 1 (16.7%) 1 (9.1%) 0 (0.0%) 1.000 
 Illicit Drugs 0 (0.0%) 0 (0.0%) 1 (9.1%) 0 (0.0%) 1.000 
ASA Status     0.063 
 Class I 4 (66.7%) 1 (16.7%) 4 (36.4%) 0 (0.0%)  
 Class II 2 (33.3%) 3 (50.0%) 5 (45.5%) 2 (50.0%)  
 Class III 0 (0.0%) 1 (16.7%) 2 (18.2%) 2 (50.0%)  
 Class IV 0 (0.0%) 1 (16.7%) 0 (0.0%) 0 (0.0%)  
Statistical significance observed in post-hoc analysis; *: p<0.05; **: p<0.01 
Age, Cohort 1 vs 3: p=0.003 
BMI, Cohort 1 vs 2: p=0.003, 1 vs 3: p=0.006, 1 vs 4: p<0.001 
BMI categorical, Cohort 1 vs 2: p=0.006, 1 vs 3: p=0.009, 1 vs 4 p=0.005 
619 
 26 
However, patients who underwent peri-areolar incision were significantly younger compared to the 620 
pre-July 2019 “hockey stick” group (p=0.003), and had lower BMI when compared with the other 621 
3 cohorts (p<0.001). They were also associated with a significantly smaller volume of liposuction 622 
than the pre-July (p=0.001) and post-July 2019 “hockey stick” groups (p =0.005), and a shorter 623 
duration of surgery, (p=0.018) (Table 6).  624 
Table 6. Operative details across incision type 625 








Hockey Stick  
after 7/2019 
(n=4) p 
Volume of liposuction 43.3 ± 106.1 350.0 ± 427.8 486.4 ± 281.2 650.0 ± 2677 0.008** 









Peri-operative morbidity 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1.000 
Duration of surgery 126.0 ± 42.5 206.8 ± 58.1 186.6 ± 34.9 216.3 ± 31.1 0.027* 
Statistical significance observed in post-hoc analysis; *: p<0.05; **: p<0.01 
Liposuction, Cohort 1 vs 3: p=0.001, 1 vs 4: p=0.005 
Volume of Tissue Removed, Cohort 1 vs 3: p=0.026, 1 vs 4: p=0.001 
Duration of Surgery, Cohort 1 vs 2: p=0.018, 1 vs 4: p=0.018 
 626 
In addition, patients who received the peri-areolar incision had a significantly smaller volume of 627 
tissue removed than patients in the pre-July 2019 (p<0.026) and post-July 2019 “hockey stick” 628 
(p=0.001) groups (Figure 6). 629 
Figure 6. Comparison of operative details across incision types 630 
 631 
 632 
* p<0.05 633 
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In terms of post-operative details, there were no significant differences documented in the 634 
complications, post-operative ED visits, re-admissions, and re-operations amongst other cohorts. 635 
In addition, the time ranges for recovery time (i.e. physical activity with limitation versus that 636 
without) were comparable among the groups (Figure 7).  637 
Figure 7. Weeks to any activity by individual patients undergoing various incision types  638 
 639 
 640 
Note: Each dot represents an individual patient, while the horizontal bars represent the mean recovery time of each 641 
group.  642 
Of note, there were differences in time duration between surgery to BODY-Q 643 
administration between groups, with the inframammary fold incision cohort having a longer time 644 
duration (1249.2 ± 253.7 days) compared to the other three cohorts (p<0.001) (Table 7). 645 
Additionally, the difference in time from surgery to BODY-Q administration between the patients 646 
who underwent the “hockey stick” incision before (706.6 ± 260.1 days) and after (194 ± 112.1 647 
































Average time of follow-up 
(days) 
166.2 ± 
203.52 73.2 ± 114.6 205.5 ±280.2 53.0 ± 53.6 0.570 
Average time from surgery 
to BODY-Q (days) 
506.0 ± 171.0 1249.2 ± 253.7 706.6 ± 260.1 194 ± 112.1 <0.001** 
Complications (Any) 3 (50.0%) 2 (33.3%) 6 (54.5%) 2 (50.0%) 0.945 
 Wound dehiscence 0 (0.0%) 1 (16.7%) 4 (36.4%) 2 (50.0%) 0.227 
 Asymmetry 1 (16.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0.593 
 Hematoma 2 (33.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0.103 
 Seroma 1 (16.7%) 1 (16.7%) 1 (9.1%) 0 (0.0%) 1.000 
 Infection 0 (0.0%) 1 (16.7%) 2 (18.2%) 0 (0.0%) 0.865 
 Fat Necrosis 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1.000 
 Nipple Necrosis 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1.000 
Post-operative ED visits  1 (16.7%) 1 (16.7%) 4 (36.4%) 2 (50.0%) 0.608 
Re-admissions 1 (16.7%) 1 (16.7%) 1 (9.1%) 0 (0.0%) 1.000 
Re-operations 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1.000 
 Nipple reconstruction 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Fat grafting 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Scar revision 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Hematoma 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 Mastopexy 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
Recovery Time       
Physical Activity     0.209 
 <2 weeks 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (25.0%)  
 2-4 weeks 4 (66.7%) 3 (50.0%) 2 (18.2%) 2 (50.0%)  
 4-6 weeks 0 (0.0%) 2 (33.3%) 4 (36.4%) 0 (0.0%)  
 6-8 weeks 2 (33.3%) 1 (16.7%) 4 (36.4%) 1 (25.0%)  
 8+ weeks 0 (0.0%) 0 (0.0%) 1 (9.1%) 0 (0.0%)  
Physical Activity without 
Limitation     0.685 
 <2 weeks      
 2-4 weeks 1 (16.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%)  
 4-6 weeks 1 (16.7%) 2 (33.3%) 2 (18.2%) 1 (25.0%)  
 6-8 weeks 1 (16.7%) 3 (50.0%) 4 (36.4%) 1 (25.0%)  
 8+ weeks 3 (50.0%) 1 (16.7%) 5 (45.5%) 2 (50.0%)  
Statistical significance observed in post-hoc analysis; *: p<0.05; **: p<0.01 
Time from surgery to BODY-Q, Cohort 1 vs 2: p<0.001, 2 vs 3: p<0.001, 2 vs 4: p<0.001, 3 vs 4: p=0.006 
 
In terms of analysis by BMI, the wound dehiscence rate of the patients in the group of BMI 649 
>30 was significantly increased (p<0.008), compared to patients of BMI <25 (0% versus 42.9%, 650 
p<0.008). (Table 8). Other post-operative outcomes, including number of post-operative ED visits, 651 
re-admissions, re-operations, and recovery time did not significantly differ among weight 652 





Table 8. Post-operative complications by BMI 
 
 






Average time of follow-up (days) 113.5 ± 167.0 45.3 ± 27.4 188.4 ± 256.5 0.681 
Average time from surgery to BODY-
Q (days) 
664.1 ± 303.1 678.3 ± 353.2 758.1 ± 505.5 0.87 
Complications (Any) 4 (40.0%) 1 (33.3%) 8 (57.1%) 0.65 
 Wound dehiscence 0 (0.0%) 1 (33.3%) 6 (42.9%) 
0.048*
* 
 Asymmetry 1 (10.0%) 0 (0.0%) 0 (0.0%) 0.481 
 Hematoma 2 (20.0%) 0 (0.0%) 0 (0.0%) 0.432 
 Seroma 1 (10.0%) 0 (0.0%) 2 (14.3%) 1 
 Infection 1 (10.0%) 0 (0.0%) 2 (14.3%) 1 
 Fat Necrosis 1 (10.0%) 0 (0.0%) 7 (50.0%) 1 
 Nipple Necrosis 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
Post-operative ED visits  1 (10.0%) 0 (0.0%) 7 (50.0%) 0.063 
Re-admissions 1 (10.0%) 0 (0.0%) 2 (14.3%) 1 
Re-operations 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
 Nipple reconstruction 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
 Fat grafting 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
 Scar revision 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
 Hematoma 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
 Mastopexy 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 
Recovery Time      
Physical Activity    0.359 
 <2 weeks 0 (0.0%) 0 (0.0%) 1 (3.7%)  
 2-4 weeks 6 (60.0%) 1 (33.3%) 11 (40.7%)  
 4-6 weeks 0 (0.0%) 2 (67.7%) 6 (22.2%)  
 6-8 weeks 4 (40.0%) 0 (0.0%) 8 (29.6%)  
 8+ weeks 0 (0.0%) 0 (0.0%) 1 (3.7%)  
Physical Activity without Limitation    0.353 
 <2 weeks 1 (10.0%) 0 (0.0%) 0 (0.0%)  
 2-4 weeks 2 (20.0%) 0 (0.0%) 0 (0.0%)  
 4-6 weeks 2 (20.0%) 1 (33.3%) 4 (28.6%)  
 6-8 weeks 5 (50.0%) 2 (67.7%) 6 (42.9%)  
 8+ weeks 0 (0.0%) 0 (0.0%) 4 (28.6%)  
Statistical significance observed in post-hoc analysis; *: p<0.05; **: p<0.01 
Wound Dehiscence, Normal weight vs Obese: p=0.008 
 657 
BODY-Q 658 
The BODY-Q survey was administered in order to assess patient satisfaction after chest 659 
masculinization surgery. By cohort, patients who underwent the “hockey stick” incision before July 660 
2019 (Cohort 3) had significantly higher scores (98.7 ± 4.2) in the “Satisfaction with 661 
Doctor/Surgeon” module compared to the peri-areolar incision group (85.83 ± 13.45) (p<0.001) 662 
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(Table 9). All of the other modules, in addition to overall score, did not have significant differences 663 
amongst the cohorts.   664 
Table 9. BODY-Q modules by incision type 665 
 












Appearance-Related Psychosocial Distress 32.50 ± 25.68 27.83 ± 23.37 25.73 ± 8.6 44.3 ± 18.8 0.704 
Social Function 54.67 ± 13.49 65.67 ± 14.39 61.0 ± 13.6 60.5 ± 7.3 0.652 
Psychological Function 58.17 ± 17.60 65.17 ± 9.75 67.6 ± 14.6 65.0 ± 10.9 0.847 
Physical Function 22.00 ± 29.83 63.00 ± 40.71 22.8 ± 29.8 34.5 ± 9.5 0.080 
Satisfaction with Chest 67.33 ± 27.35 62.83 ± 34.45 89.6 ± 11.9 72.0 ± 24.7 0.066 
Satisfaction with Nipples 63.00 ± 27.12 68.33 ± 39.33 86.8 ± 15.9 74.3 ± 25.3 0.307 
Appraisal of Body Contouring Scars 86.50 ± 14.83 62.50 ± 32.20 75.4 ± 20.4 68.5 ± 16.9 0.306 
Satisfaction with Doctor/Surgeon 85.83 ± 13.45 87.33 ± 16.92 98.7 ± 4.2 89.3 ± 11.5 
0.050*
* 
Satisfaction with Medical Team 90.50 ± 10.99 66.67 ± 39.79 95.0 ± 9.5 84.0 ± 8.5 0.115 
Satisfaction with Office Staff 84.67 ± 17.84 88.33 ± 22.81 100.0 ± 0.0 77.0 ± 29.2 0.069 
Overall Score 645.17 ± 65.51 657.67 ±178.55 722.7 ± 63.8 669.3 ± 33.7 0.219 
Statistical significance observed in post-hoc analysis; *: p<0.05; **: p<0.01 
Satisfaction with Doctor/Surgeon, Cohort 1 vs Cohort 3: p<0.001 
 
Cohort 3 (“hockey stick” before July 2019) had the tendency of higher scores (89.6 ± 11.9) 666 
in the “Satisfaction with Chest” module compared to other groups, yet the difference did not 667 
achieve statistical significance (p<0.066). When classified by BMI, differences were seen within 668 
the “Appraisal of Body Contouring Scars” module (p<0.010), with patients of BMI<25 669 
demonstrating significantly higher scores (87.70 ± 12.31), thus higher satisfaction, compared to 670 
patients of BMI >30 (69.00 ± 17.62) (p<0.006) (Table 10). 671 
Table 10. BODY-Q modules by patient BMI 






Appearance-Related Psychosocial Distress 27.00 ± 22.04 53.00 ± 15.72 28.07 ± 22.33 0.154 
Social Function 56.80 ± 13.96 53.00 ± 10.82 84.86 ± 11.67 0.151 
Psychological Function 67.10 ± 19.06 55.67 ± 13.43 64.71 ± 8.41 0.312 
Physical Function 25.40 ± 35.56 12.00 ± 20.79 43.50 ± 32.31 0.127 
Satisfaction with Chest 79.70 ± 25.98 62.33 ± 54.37 76.50 ± 17.19 0.653 
Satisfaction with Nipples 74.60 ±26.80 66.67 ± 57.74 78.14 ± 19.72 0.926 
Appraisal of Body Contouring Scars 87.70 ± 12.31 51.33 ± 44.86 69.00 ± 17.62 
0.010
** 
Satisfaction with Doctor/Surgeon 91.50 ± 12.44 87.67 ± 21.36 93.14 ± 10.45 0.975 
Satisfaction with Medical Team 93.50 ± 9.35 59.33 ± 52.55 86.50 ± 17.32 0.377 
Satisfaction with Office Staff 90.80 ± 15.48 100.00 ± 0.00 88.43 ± 21.88 0.703 
Overall Score 694.10 ± 89.53 601.00 ± 232.41 692.86 ± 63.60 0.971 
Statistical significance observed in post-hoc analysis; *: p<0.05; **: p<0.01 
Appraisal of Body Contouring Scars, Normal Weight vs Obese: p=0.007 
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Discussion of Study Results  672 
This study details the technical approach of “hockey stick” incision, a refinement of 673 
existing DMFNG for transgender men and non-binary individuals. Previously published studies, 674 
most notably by Berry et al, Lo Russo et al and Gonzalez et al, described alternative efforts to 675 
masculinize the chest wall by including a lateral extension of the inframammary fold incision into 676 
the axilla to emulate the lateral border of the pectoralis (17-19). The technique described here 677 
modifies prior techniques through rotation of lateral chest wall tissue, anteriorly and superiorly into 678 
the axilla, cutting off excess tissue and minimizing the excess tissue at the tail of Spence and 679 
tightening the skin at the lateral chest wall. In performing these technical refinements, it has been 680 
suggested that such alignment of a cis-masculine appearing chest and masculine gender identity 681 
improves gender dysphoria for some patients.  682 
In terms of differences between the incision types, not surprisingly, we found that patients 683 
who underwent “hockey stick” and inframammary fold incisions had significantly greater tissue 684 
removed and less liposuction compared to patients who received the peri-areolar incision approach. 685 
This reflects the selection of surgical type, as patients who are offered peri-areolar incisions 686 
typically have a relatively lower BMI (28,35,36). When classified by BMI, it was found that 687 
patients of larger body habitus (BMI >30) had a significantly higher rate of wound dehiscence than 688 
normal weight patients. The need for additional tissue removal to correct lateral skin excess has 689 
longer incisions and extension into the axilla, risking dehiscence, as this area tends to be under 690 
additional tension while performing daily activities (i.e. abduction arm movements, particularly 691 
when wearing “pull over” garments) (30, 35, 36). Despite the discrepancy in volume of tissue 692 
removed and increased complication rate in higher BMI patients, this study found no differences 693 
in terms of patient satisfaction by incision type. Taken together, these findings suggest that the 694 
“hockey stick” approach confers comparable overall clinical outcomes relative to those associated 695 
with the peri-areolar incision. This is particularly notable since the peri-areolar incision is 696 
associated with fewer complications and are generally performed in healthier patients (28,35,36). 697 
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In terms of differences in patient satisfaction, BODY-Q results between patients who 698 
underwent the different incision types, the only statistically significant finding was that patients 699 
who underwent the “hockey stick” incision before 7/2019 had higher satisfaction with their surgeon 700 
than those who had surgery through a peri-areolar incision, even though all patients included in the 701 
analysis who underwent those two types of procedures were performed by the same surgeon (J.P.). 702 
This finding could be related to increased time of surgery to survey administration. This variable 703 
is especially important to consider as an influential factor for healing time and its potential 704 
association with patient satisfaction from chest masculinization surgery. Another explanation for 705 
this finding may be the possibility of increased doctor-patient communication, which has been 706 
linked with improved patient-reported outcomes (56).  The process of learning from the patient, 707 
eliciting their concerns, and implementing and refining the surgical technique may have resulted in 708 
increased communication between the senior author and patients during that time period (56).   709 
In our analysis of BODY-Q results, other modules appeared to approach, yet not reach 710 
significance. In contrast to the findings of van de Grift et al., the “Satisfaction of Chest” and 711 
“Satisfaction of Nipples” modules did not yield significant differences between cohorts. Patients 712 
who underwent the “hockey stick” incision in our study, particularly before July 2019, reported 713 
scores in the “Satisfaction of Chest” module that approached statistical significance, and that could 714 
be limited by our smaller sample size (p = 0.066) (49). The patients in this cohort did have a 715 
significantly longer duration between the surgery and the administration of the BODY-Q survey. 716 
Thus, it is important to recognize the potential impact that time, and therefore, healing time from 717 
intervention, has on patient satisfaction (47). Future studies should explore the long-term 718 
satisfaction of the “hockey stick” incision through a larger sample size and uniform pre- and post-719 
operative time-points for survey administration (44). 720 
With respect to stratification by BMI, our study revealed that patients with normal body 721 
weights had a significantly higher BODY-Q score, in the “Appraisal of Body Contouring of Scars” 722 
module, as compared to obese individuals.  It is unclear, however, why body weight might impact 723 
 33 
level of scrutiny of scars. It is important to note that preferences and expectations related to scarring, 724 
as well as decisions regarding whether or not to identify as transgender, vary greatly among patients 725 
and should be considered in pre-operative discussions.  While for some, scarring is viewed as 726 
unattractive or potentially disfiguring, whereas others consider their surgical scars as positive marks 727 
of identity, resilience, or pride.  For others who may not choose to publicly share their gender 728 
identities for personal reasons, scars are potentially endangering identifiers. These considerations 729 
were not accounted for in the BODY-Q module (49-51). This also underscores the fact that the 730 
appropriate reconstructive considerations are highly individualized, and that satisfaction is not 731 
necessarily a function of exclusively objective variables (44, 45, 47).  732 
Study Limitations  733 
To our knowledge, this study is the first to assess BODY-Q scores by incision type, and 734 
serves as a starting point for future studies, with greater statistical power, to contribute to the 735 
evidence-base for chest masculinization surgery. However, there are several limitations to our study 736 
that warrant consideration. First, the small sample size of 27 patients restricts the ability to reach 737 
statistical significance within the majority of our analyses, although our response rate (37%) is 738 
higher than the requirement for a general questionnaire (20%) (55).  Second, all analyzed patients 739 
intentionally underwent a surgical reconstruction that achieved an aesthetic result that resembled a 740 
cis-masculine chest, which may not apply to patients who identify as trans-masculine or non-binary. 741 
These considerations are beyond the scope of the present study, but should be explored in future 742 
investigations. Third, our analysis and video communication does not include photographs of 743 
patients of varying racial and ethnic background, thus missing an opportunity to examine what 744 
effect skin color may be on the appraisal of scars (57). Fourth, previous studies have established 745 
that worse health status and obese body type confer lower satisfaction scores; our cohorts consisted 746 
of patients with differing body types and health conditions, and such factors could have impacted 747 
our results (58-60). Despite these limitations, we believe that this study provides a useful technical 748 
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approach towards chest masculinization surgery, and additionally, contributes helpful knowledge 749 
regarding patient satisfaction and clinical outcomes.  750 
Study Conclusion 751 
The “hockey stick” incision with free nipple grafts may alleviate gender dysphoria through 752 
reconstruction of a cis-masculine appearing chest in transgender men. Our results suggest that this 753 
approach is a safe and effective technique for chest masculinization, particularly in those patients 754 
with moderate- to large and ptotic breast tissue, and for whom gender congruence is achieved with 755 
cis-masculine models. Additionally, the “hockey stick” approach confers patient satisfaction and 756 
clinical outcomes that are comparable with free nipple grafts and peri-areolar incision types. Our 757 
investigation serves as a starting point for future studies to further contribute to the evidence-base 758 
for chest masculinization. 759 
The Barriers to Deliver Gender-Affirming Care and the Actions to Mitigate Them 760 
While important strides have been taken by plastic surgeons to refine techniques for chest 761 
masculinization (as well as for other gender-affirming surgical interventions), there are notable 762 
considerations that may compromise the ability for transgender and non-binary patients to 763 
successfully access and receive gender-affirming care, as well as routine healthcare.  764 
Historical Disparities  765 
Transgender and gender-diverse individuals face tremendous disparities in their health and 766 
healthcare. Compared with cis-gender people, they have higher rates of mood disorders, tobacco 767 
and substance use, and HIV and other sexually transmitted infections (STI). Nearly half (41%) of 768 
respondents had attempted suicide – at a rate 26 times higher than that of the general population 769 
(7-12). The medical issues have been amplified by pervasive maltreatment from medical providers. 770 
Moreover, the 2015 U.S Transgender Survey has been the largest survey to date that examines the 771 
experiences of more than 27,000 transgender people in the United States (61). One-third of those 772 
who saw a health care provider in the past year reported having at least one negative experience 773 
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related to being transgender, such as being refused treatment, verbally harassed, or physically or 774 
sexually assaulted, or having to teach the provider about transgender people in order to get 775 
appropriate care, with higher rates for people of color and people with disabilities (61). Nearly a 776 
quarter (23%) of respondents did not see a doctor when they needed to because of fear of being 777 
mistreated as a transgender person (61). Furthermore, the outstanding disparities have been fueled 778 
by pervasive structural, interpersonal, and individual-level stigma that not only jeopardize access 779 
to primary care, but also to gender-affirming services.  780 
Black and Latinx transgender people are susceptible to suboptimal health care access, 781 
owing to social and economic inequities as well as racial biases in medicine (7). Compared with 782 
White transgender individuals, these populations have more unmet medical needs and greater 783 
difficulty obtaining access to gender-affirming care. In fact, a 2018 study using the National 784 
Surgery Quality Improvement Program (NSQIP) and National Inpatient Sample (NIS) Databases 785 
concluded that the Black/African American race was associated with an increased risk of 786 
reoperation and readmission after gender-affirming surgical procedures (62). This underscores how 787 
healthcare disparities are heightened for transgender people of color and of ethnic minorities. 788 
In order to mitigate such difficulties in accessing healthcare, there have been advances 789 
within the digital health innovation and entrepreneurship sector to provide services for the 790 
transgender and gender-expansive communities. To name a few, Euphoria (Solace, Bliss, Clarity), 791 
FOLX Health, and Plume are promising companies that are revolutionizing the model of gender-792 
affirming care (62-68).  793 
Euphoria is an umbrella organization that leverages multiple technologies to address the 794 
social, economic, and healthcare needs of the LGBTQ+ population. Based out of Spokane, 795 
Washington, the company was founded by Robbi Katherine Anthony and Patrick McHugh. In 796 
2016, Anthony had won the HackOut, the nation’s only competition geared specifically towards 797 
aspiring LGBTQ+ technology entrepreneurs (62-64). Euphoria includes Solace, Bliss, and Clarity.  798 
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Solace “provides information and resources to guide transgender people through whatever process 799 
of gender transition they desire (62).” Planning its launch for 2021, Bliss will serve as a 800 
“revolutionary savings application for the transgender community” and help finance gender-801 
affirming treatments for patients (63). Clarity helps users gain greater insight into their gender and 802 
sexuality in a way that's dignified and affirming (64). To date, the company has raised $240,000 in 803 
funding, and been downloaded by thousands of users worldwide.  804 
FOLX Health has emerged as another pioneer in this field, and has been designed with the 805 
medical needs and goals of the LGBTQ+ community in mind (65). The company offers gender 806 
reaffirming hormone therapy, erectile dysfunction treatment, at-home STI testing, one-on-one 807 
consultations, and prescriptions priced with or without insurance. FOLX is also assisting with 808 
family creation, an aspect of health care not often tailored for the queer and trans communities. 809 
Founded by A.G. Bernstein, the company secured $4.4 million from Bessemer Venture Partners, 810 
Define Ventures, and Polaris Partners in December 2020 (65).  811 
Plume has been rated as one of the fastest-growing trans technology companies in the 812 
nation. Founded by Jerrica Kirkley and Dr. Matthew Wetschler in 2019, Plume is a Denver-based, 813 
direct-to-consumer telehealth company that provides medical consultation and gender-affirming 814 
hormone therapy for transgender patients (66). As a trans woman, family practice physician and 815 
educator, Dr. Kirkley built Plume in order to radically increase access to gender-affirmation 816 
services. For a monthly fee of $99, Plume clinicians will create a custom treatment plan for patients, 817 
which can include prescriptions of testosterone, estrogen and testosterone blockers to help 818 
individuals align their physical body with their identified gender. Nearly 80 percent of Plume’s 819 
clinical team identifies as trans, and more than half of the company’s business side is comprised of 820 
transgender individuals. In June 2020, the company successfully raised $2.9 million from General 821 




Video 3. Conversation with Dr. Jerrica Kirkley, Co-Founder and Chief Medical Officer, 825 







Lack of Medical and Resident Education  833 
Medical education surrounding gender-affirming healthcare is especially vital – given the 834 
unique considerations and knowledge base required to ensure a high quality of care for transgender 835 
and non-binary patients. In fact, a survey of 101 trans females revealed that the lack of access to a 836 
knowledgeable provider was the greatest reported barrier and it persisted despite improvement with 837 
regard to other barriers to care (13-16). Moreover, given the engagement of multiple specialties 838 
typically involved in gender-affirming care and the increasing demand for these services, a 839 
standardized education for transgender and non-binary healthcare is warranted. Despite such 840 
importance, there has been a notable lag in the availability of a formalized, integrated curriculum 841 
that describes the psychological, medical, and surgical aspects of gender-affirming care. 842 
Moreover, in a systematic review of transgender medical education, Nolan et al. assessed 843 
over 966 publications to assess the types of educational formats that were utilized to teach MD/DO 844 
students in the United States and Canada. Analysis of ten publications revealed that 845 
interdisciplinary interventions, post-residency training including continuing medical education 846 
(CME) courses, and online web courses were effective in improving competencies related to 847 
transgender health care. Some institutions discuss such topics throughout the pre-clinical 848 
endocrinology, reproductive, or pediatric curriculum, while others refer to formal clinical 849 
experiences and electives within multiple specialties (13). Some dive into the considerations for 850 
screening, while others focused more on the role of medical and surgical interventions for the 851 
transition process. Of note, none of the articles provided educational instruction regarding the 852 
health considerations for non-binary patients; this highlights the need to revise medical education 853 
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to best cater to this population. Moreover, given the absence of long-term follow-up data and varied 854 
nature of intervention types, it was difficult for the researchers to determine which type of teaching 855 
method and formats are most effective in educating medical students and aspiring healthcare 856 
professionals on topics within transgender healthcare and gender-affirming care (13). Future 857 
educational opportunities should involve engagement within multiple disciplines in order to reflect 858 
the complexities and breadth of such care, and ultimately position trainees well for caring for 859 
transgender and gender-expansive patients. Additionally, research studies can assess the 860 
competency in order to determine which teaching method is most effective, and promote medical 861 
schools and residency programs to have a standardized and ideally longitudinal curriculum for 862 
transgender, non-binary, and gender-affirming healthcare. Within the context of certain specialties 863 
(i.e. plastic surgery, endocrinology, psychiatry, urology), a uniquely tailored curriculum and 864 
clinical education is necessary.  865 
At Yale University School of Medicine, the Plastic and Reconstructive Surgery Interest 866 
Group (PRSIG) and the Dean’s Advisory Council (DAC) will host a panel entitled, “Introduction 867 
to Gender-Affirming Care” in February 2021. As a co-leader and gender-affirming outcomes 868 
researcher, I was particularly drawn to the unmet need for transgender medical education and was 869 
inspired to share such knowledge with my peers. Our panel will comprise of two speakers: Dr. 870 
Robert Travieso, 2019 graduate of the Yale Plastic and Reconstructive Surgery Program and 871 
current Gender and Microsurgery fellow at Johns Hopkins University, and Allister Hirschman, a 872 
Physician Assistant who serves as a surgical float and a trans-man who has engaged extensively 873 
with the DAC and the division to strengthen research efforts. The aims of the event are to help 874 
students: 1) gain a basic understanding of the medical and/or surgical treatment options for 875 
individuals seeking gender transition; 2) understand some of the social/structural elements involved 876 
in the transition process (i.e. legal, insurance, etc), and 3) gain appreciation for some of the ethical 877 
and social dilemmas faced when providing transition care. While the panel is not to serve as a 878 
comprehensive summary of gender-affirming care, we hope to introduce medical students to 879 
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important topics, provide them with resources, and ultimately, motivate them to engage in 880 
opportunities to learn further.  881 
Insurance Landscape  882 
Patients with gender dysphoria seeking to undergo gender affirmation surgery are often 883 
challenged by lack of insurance coverage. According to the 2015 National Transgender 884 
Discrimination Survey, 50% of transgender adults reported denial of coverage for gender-affirming 885 
surgery and 25% reported denial for hormones (61). While the insurance landscape has evolved 886 
over the past five years, there are notable discrepancies among state and private health plans for 887 
the coverage of facial, chest, and genital surgeries for the transgender and non-binary communities.  888 
This is particularly essential, as the number of patients who have Medicaid or Medicare insurance 889 
status have increased by three-fold (69-70).  890 
Several studies have categorized such inconsistencies in coverage (70-79). Cohen et al. 891 
performed an analysis of 124 insurance companies and found a discrepancy between the coverage 892 
of chest masculinization and chest feminization (71). Furthermore, while the vast majority of 893 
insurance companies (98%) include some degree of reimbursement for chest masculinization, only 894 
a minority (20%) covered chest feminization for transgender women. Of note, nipple-areola-895 
complex was covered in only 20% of companies. For facial feminization surgery, Gadakaree et al. 896 
found that only 27 (18%) of the 150 insurance companies analyzed had favorable policies for 897 
coverage (76). For genital surgery, Ngaage et al. found that only 17% of the 52 analyzed insurers 898 
held criteria that matched international recommendations (74). Beyond private health plans, states 899 
vary widely in their coverage of gender-affirming procedures. This is evidenced by the recent 2019 900 
by Pew Charitable Trust (Figure 8) (79). While differing political viewpoints and cultural opinions 901 
may play a role in the state-level provision of care, it is paramount to understand the public health 902 
consequences of not alleviating gender dysphoria – such as increased prevalence of HIV and other 903 
STIs, increased community violence, and societal rates of depression, anxiety, and suicide.  904 
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In the context of chest masculinization surgery, plastic surgeons must balance the two-fold 917 
prioritization of medically necessary and aesthetic reconstruction. The crux of the discussion lies 918 
in communicating the medical necessity of the intervention. Moreover, in order to do so, there is a 919 
schematic that might be helpful to consider. One could view parallels between chest 920 
masculinization surgery and breast cancer mastectomy with reconstruction (80-82). In both cases, 921 
the primary pathology involves presence of breast tissue; however, the underlying diagnosis differs 922 
between these two types of patients, as the former being gender dysphoria (as signified by 923 
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incongruous breast tissue) and the latter, cancer (as signified by malignant breast tissue). Within a 924 
typical mastectomy, surgical oncologists remove cancerous breast tissue, with their dissections 925 
informed by pathology reports, as well as the stage and grade of cancer. Depending on the patient’s 926 
preferences and prognosis, plastic surgeons then often perform either autologous or implant-based 927 
reconstruction in order to restore feminine identity and sense of self (as appropriate to specific 928 
patient). This reconstruction is classified as medically-necessary, given its association with an 929 
underlying pathology and the need to restore emotional and psychological well-being (80-82). 930 
Plastic surgeons perform chest masculinization surgery by first removing incongruous breast tissue 931 
in transmasculine or non-binary patients. Furthermore, there are additional considerations in how 932 
to approach further reconstruction, in this case how to achieve an aesthetic result that aligns with a 933 
patient’s gender identity and sense of self. In some cases, this result may intentionally resemble a 934 
chest that is of a cis-gender male (someone with a male gender identity and an assigned sex of male 935 
at birth). This often entails the simulation of the infero-lateral margin of the pectoralis major 936 
through the extension of either the upper or lower incision into the axilla (33-35). In addition, the 937 
lengthening of the lateral incision has been described to decrease the risk of puckering or tethering 938 
at the lateral chest wall. Re-construction of a cis-male modelled chest, epitomized by the definition 939 
of the pectoralis muscle, after the resection of dysphoric feminine breast tissue, is often restorative 940 
of gender congruence for transgender men; this reconstruction maintains several parallels with a 941 
typically feminine reconstruction performed for a cis-female (someone with a female gender 942 
identity and an assigned sex of female at birth), with respect to restoring self-identity after the 943 
resection of cancerous breast tissue and subsequent reconstruction (80-82). We propose this 944 
schematic to not perpetuate any stigmatization of individuals whose gender identity expands 945 
beyond the cis-normative gender binary and or make false assumptions that all transmasculine 946 
patients benefit from chest masculinization surgery. 947 
At a high level, the implications of insurance reimbursement for gender-affirming 948 
interventions are great for the transgender and non-binary communities. Moreover, to determine 949 
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the extent of financial coverage, insurance companies often refer to data, which include cost 950 
savings, patient satisfaction, and clinical outcomes (40). Thus, in order to best advocate for these 951 
patients, research studies should be performed in order to quantify the impact of gender-affirming 952 
surgeries, from clinical and satisfaction perspectives, and continue to communicate their 953 
classification as medically necessary. Nonetheless, this very act often warrants describing 954 
“pathology” with gender dysphoria, and may perpetuate further marginalization and stigmatization 955 
of the transgender and non-binary community. Individuals may remedy their dysphoria through the 956 
expression of a non-binary identity, and in doing so, may forego medical or surgical 957 
interventions. Such considerations must be taken into account.  958 
Political Environment  959 
In recent months, the rights of the LGBTQ community, especially those who identify as 960 
transgender or gender-expansive, emerged as pivotal topics of discussion within presidential 961 
election and thereafter. In a town hall on October 15, 2020, a mother of a transgender eight-year-962 
old girl referenced the legislative actions undertaken by the Trump Administration and asked soon-963 
to-be president-elect Joseph R. Biden, Jr. a key question: “How will you as president reverse the 964 
dangerous and discriminatory agenda and ensure that the lives and rights of lesbian, gay, bisexual, 965 
transgender, and queer (LGBTQ) people are protected under U.S. law?” (84) Enacted by the Obama 966 
Administration in 2008, the Affordable Care Act (ACA) had aimed to provide equitable and 967 
accessible healthcare to individuals, regardless of gender, sexual orientation, and gender identity 968 
(85-86). The ACA specifically promoted greater access to care through instituting Medicaid 969 
expansion efforts in multiple states, removing exclusions of transition care, and finally, forgoing 970 
issue of pre-existing conditions such as transgender identity. Gender-affirming surgical procedures, 971 
such as facial feminization and chest masculinization, were widely classified as medically-972 
necessary given their collective ability to alleviate gender dysphoria for patients.   973 
Regardless of its strides towards restoring healthcare equity, the ACA was relentlessly 974 
attacked and effectively dismantled by the Trump Administration. The administration’s legislative 975 
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efforts have tremendously impacted the transgender and gender-expansive community. Over the 976 
course of a nearly four-year term, the Trump Administration revoked many rights of transgender 977 
individuals in a myriad of settings – including military services, schools, homeless shelters, and 978 
school bathrooms. In addition, the administration has removed references to the LGBTQ 979 
community on various government websites. Interestingly, on June 15, 2020, the Supreme Court 980 
had issued a decision in Bostock v. Clayton that prohibited workplace discrimination by gender 981 
identity or sexual orientation (85). Despite such advances, this historic legislative victory for the 982 
LGBTQ community was quickly short-chained only four days later when the Department of Health 983 
and Human Services revised the nondiscrimination provision (Section 1557) of the Affordable Care 984 
Act and removed all references to gender identity and sexual orientation (86-87). While several 985 
federal districts have issued injunctions that restrict the rule’s enforcement, some provisions still 986 
remain active. Thus, there is much uncertainty surrounding the individual state protocols in the 987 
treatment of transgender or gender-expansive individuals on the basis of gender identity or sexual 988 
orientation.  989 
Given these legislative moves and growing partisanship within our nation, the health and 990 
healthcare of the transgender and gender-expansive community hang in a balance. In order to 991 
address the rights of the LGBTQ+ community, President-elect Biden has proposed the Equality 992 
Act, and plans to make its enactment during his first 100 days a top legislative priority (88). At a 993 
high level, the act aims to achieve the following:  994 
• Protect LGBTQ+ people from discrimination. 995 
• Support LGBTQ+ youth. 996 
• Protect LGBTQ+ individuals from violence and work to end the epidemic of violence 997 
against the transgender community, particularly transgender women of color.  998 
• Expand access to high-quality health care for LGBTQ+ individuals. 999 
• Ensure fair treatment of LGBTQ+ individuals in the criminal justice system. 1000 
• Collect data necessary to fully support the LGBTQ+ community. 1001 
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• Advance global LGBTQ+ rights and development. 1002 
A recent New England Journal of Medicine (NEJM) article calls for “a new antidiscrimination 1003 
law, [which should] require clear, affirmative coverage of transition-related care in all plans, 1004 
including self-insured employer plans and the Veterans Health Administration’s TriCare plans 1005 
(which currently exclude gender-affirming surgeries)” (89). Additionally, Strouma et al. state that 1006 
the “medical profession has an ongoing obligation to act by expanding high-quality accessible care 1007 
for transgender and nonbinary people” (89). The first steps toward this end include “training, 1008 
community-engaged care improvement and research, and a commitment to the creation of health 1009 
care environments that are as welcoming for transgender and nonbinary patients as they are for 1010 
cisgender people” (89). As Biden and his team enter the White House and a Democrat-majority 1011 
Senate, such aspirations may soon be fulfilled for the transgender and non-binary individuals.  1012 
Coronavirus Pandemic 1013 
The Coronavirus pandemic has exacerbated the underlying healthcare disparities that 1014 
impact transgender patients. In April 2020, the UCLA Williams Institute issued a report that 1015 
detailed the vulnerabilities to COVID-19 among the 1.4 million transgender adults in the United 1016 
States (90). This virus has impacted this population in several ways. First, homelessness 1017 
disproportionately afflicts transgender adults, and thus, might impede their ability to follow social 1018 
distancing guidelines and regular hand washing. Second, social isolation, unemployment, and 1019 
financial strain have further exacerbated high rates of suicide among transgender individuals and 1020 
violence against this community. Of note, 34 transgender or non-confirming individuals have been 1021 
fatally killed this year alone, many of whom were of Black or Latino descent. Third, stay-at-home 1022 
orders and quarantine measures have been associated with increased rates of intimate partner 1023 
violence, which are already elevated among transgender individuals. And fourth, transgender 1024 
individuals face high rates of co-morbidities, including asthma, diabetes heart disease, HIV, and 1025 
smoking, all of them predispose one to contract COVID-19. Within healthcare settings, transgender 1026 
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patients have historically experienced discomfort and discrimination, and ultimately, feel 1027 
disincentivized to access necessary care. In combination, these factors have widened healthcare 1028 
disparities among transgender individuals, compared to their cis-gender counterparts.  1029 
In terms of accessing gender-affirming surgery, COVID-19 has severely restricted the 1030 
access to certain procedures, including facial feminization and chest masculinization, for the 1031 
transgender and gender-expansive community. These surgeries are performed in order to help 1032 
patients overcome gender dysphoria. While the American Society of Plastic Surgeons 1033 
recommended postponing elective or non-essential cases in March 2020, this announcement did 1034 
not preclude gender-affirming surgery, a set of medically-necessary procedures. Nonetheless, a 1035 
survey that was distributed to the members of the American Council of Academic Plastic Surgeons 1036 
(ACAPS) in April 2020 found that none of the plastic surgeons who normally performed gender-1037 
affirming surgery were offering such procedures (91). Notably, one plastic surgeon shared that a 1038 
patient of theirs had attempted suicide just after their surgery was cancelled (91). This underscores 1039 
the role of gender-affirming surgery in ensuring the psychological well-being and mental health of 1040 
patients, and the grave consequences of COVID-19 on the transgender and gender-expansive 1041 
community.  1042 
In addition to clinical care, many gender-affirming research initiatives have been suspended 1043 
due to the COVID-19 pandemic. This could ultimately compromise efforts to build an evidence-1044 
base of knowledge, cultivate patient-provider relationships, and optimize surgical techniques that 1045 
benefit transgender and gender-expansive patients (92). Moreover, the pursuit of such research 1046 
endeavors is particularly critical amidst the fragmented delivery of healthcare for this community, 1047 
and may help close the gap in healthcare disparities and inequities experienced within this 1048 
vulnerable community.  1049 
The recent approval of the Coronavirus vaccine has been a historic achievement in the public 1050 
health history of the United States. In determining which populations are most susceptible to the 1051 
 46 
virus, the Center for Disease Control and Prevention (CDC) has utilized the Social Vulnerability 1052 
Index, which describes the potential negative effects on communities caused by external stresses 1053 
on human health (93). While transgender patients may be among the most socially and financially 1054 
vulnerable, it remains unclear how this community will fare in the distribution and ultimate 1055 
administration of the vaccine – given the well-documented maltreatment by providers and 1056 
difficulties in accessing care for some. There is a unique role for national societies, such as 1057 
WPATH, LGBTQ+ community networks, and social networks to voice the importance of 1058 
vaccination, and ultimately, ensure its equitable access for the transgender population.  1059 
Considerations for the Plastic Surgeon 1060 
Challenging the Assumed Goals of the Specialty 1061 
The field of plastic and reconstructive surgery is one of evolution and innovation. While 1062 
this field has contributed immensely to clinical and scientific advancement, it is important to 1063 
consider how its guiding principles and historical terminology impact modern frontiers, such as 1064 
gender-affirming surgery. Moreover, as recorded by plastic surgeons in the American College of 1065 
Surgeon handbook, plastic and reconstructive surgery focuses on the “repair, reconstruction, or 1066 
replacement of physical defects of form or function involving the skin, musculoskeletal system, 1067 
cranio- and maxillofacial structures, hand, extremities, breast and trunk, and external genitalia 1068 
(94).” While this defining language of the specialty can be reasonably applied to anatomical and 1069 
physiological issues that result from traumatic injury, congenital anomaly, or other disability, such 1070 
historical terminology presents a number of challenges when applied to the context of gender-1071 
affirming surgery.  1072 
First, the inherent assumption that plastic surgeons exclusively manage physical conditions 1073 
effectively overlooks fundamental connections between one’s physical being and general wellness, 1074 
potentially including complex relationships among physical embodiment, identity, and overall 1075 
health that have been previously described. While surgeons may generally isolate and address a 1076 
specific surgical site, comprehensive gender-affirming care requires attention to, and understanding 1077 
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of, a patient’s broader embodied experience, gender identity, and very personal goals and 1078 
expectations for surgery. Second, the terminology implies that there is a universal understanding 1079 
of what constitutes a “physical defect” and what surgical interventions might be appropriately 1080 
employed in order to address the defect (94). However, in the context of gender-affirming 1081 
procedures, there is a great degree of subjectivity in what patients and plastic surgeons perceive as 1082 
chief physical concern and the appropriate reconstruction. Furthermore, the modification of bodies 1083 
with goals or outcomes might not necessarily fit within anatomical cis-normalized binary and 1084 
gender constructs, or restoration of physiologic function. For example, non-binary patients may 1085 
find that a chest that appears neither typically masculine for feminine best aligns with their gender 1086 
identity. Moreover, a scar could be construed as a “physical defect” to plastic surgeons, or an outing 1087 
stigmata to some transgender and non-binary individuals who, for personal or safety reasons, 1088 
choose to or are forced to hide their transgender status. Other patients, however, may celebrate 1089 
surgical scars as a signifier of pride and resilience. Third, while the surgical removal of incongruous 1090 
breast tissue is the appropriate and necessary medical intervention for alleviation of gender 1091 
dysphoria, the procedure’s classification as medically necessary entails the interpretation of gender 1092 
incongruence as pathology (or discord) (95-96). While this designation may communicate the clear 1093 
medical necessity of the procedure, this risks a problematic assumption that the treatment for gender 1094 
incongruence necessitates as a procedure to transition to an opposite gender expression according 1095 
to the gender binary, and in doing so, may stigmatize against gender-expansive individuals who 1096 
might not identity with the binary and/or those who do not resort to surgical intervention for 1097 
alleviation of gender dysphoria. These nuances challenge the assumption of minimization of 1098 
scarring as a universal goal for reconstruction.  1099 
Moreover, the clinical evaluation and general approach may reflect such nuances of 1100 
providing gender-affirming surgical care for the transgender and non-binary communities.  1101 
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Clinical Evaluation  1102 
As consultants, plastic surgeons may be involved in the later stages of the transition process 1103 
for some patients. While the pre-operative consultations before gender-affirming procedures may 1104 
carry similarities with other routine surgeries, plastic surgeons have a complex, multi-faceted role 1105 
in caring for transgender and non-binary patients. In addition to prioritizing anatomic principles 1106 
regarding contouring, scarring, and nipple-areolar complex (NAC) position, plastic surgeons must 1107 
also reflect on patient-specific factors, which may include gender identity, personal and cultural 1108 
interpretations of masculinity, of femininity, sexuality, employment, anticipated recovery duration, 1109 
perception of one’s self and personal satisfaction, and the potential perception from the general 1110 
public, when determining the appropriate reconstruction (17-19). Given the inherent subjectivity 1111 
of aesthetic ideals, particularly in the non-binary population, this might present unique challenges 1112 
for plastic surgeons. Engaging in comprehensive, often longitudinal discussions and setting clear 1113 
expectations before any further intervention is essential. Similar to other pre-operative 1114 
consultations, plastic surgeons may consider the role of hormonal therapies that may predispose 1115 
patients to hypercoagulability and thus, vascular complications. The mental health status, safety, 1116 
and support systems are additionally vital to integrate in the discussion, as post-operative recovery 1117 
can be impacted dramatically by such factors. In order to strengthen care experience, plastic 1118 
surgeons may refer to the patients’ other medical providers (i.e. endocrinologist, primary care 1119 
physician, psychiatrist) and incorporate such discussions into their pre and post-operative surgical 1120 
plan (17-19). While this summary does not serve as checklist for clinical evaluation, it highlights 1121 
important considerations to optimize surgical care and recovery for transgender and non-binary 1122 
patients.  1123 
Research Efforts 1124 
As gender-affirming surgery gains popularity among the transgender and non-binary 1125 
populations, it is vital to assess clinical outcomes and patient reported satisfaction. All caregivers 1126 
at some point need to refer to the academic literature in order to adapt and improve their treatment 1127 
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approaches. This is important in surgery, as maneuvers are often adopted or rejected based on 1128 
review and critical analysis. When surgical procedures are performed well, patients may feel 1129 
empowered to share their experiences, and as a result, help educate peers who are considering chest 1130 
masculinization surgery. Insurance providers often refer to cost savings, patient reported 1131 
satisfaction, and clinical outcomes when determining the extent of coverage in gender-affirming 1132 
care (40). While these collective perspectives relay the importance of conducting research, there 1133 
are specific and relevant challenges to consider when engaging in gender-affirming outcomes 1134 
research. There are unique lessons that our division has learned from participating in such 1135 
endeavors this year.  1136 
Key principles for studying gender affirming outcomes include the use of appropriate 1137 
terminology, understanding of the gender identity spectrum according to a range of surgical goals 1138 
and anatomical preferences, and clear delineation of study population. First, studies must utilize 1139 
up-to-date and inclusive terminology, treatment protocols, and guidelines and recommendations, 1140 
as detailed in the World Professional Association for Transgender Health Standard of Care 1141 
(WPATH SOC) Version 7 (1). This may be particularly complex, given the constant evolution of 1142 
terms and their varied perceptions amongst individuals. Furthermore, it is also important to be 1143 
mindful of the heterogeneity of different gender identities and communities. In conducting 1144 
investigations within patients of similar gender identities, the lines of investigation should, at the 1145 
outset, recognize that “one description may not fit all.”  Flexibility in terminology and expectations 1146 
of how surgical gender-affirmation may serve individual histories and expectations should be 1147 
sought. Second, stating parameters for intentional limitations of any working study is vital to 1148 
ensuring validity and generalizability; in the case of chest masculinization surgery, plastic surgeons 1149 
may refer to cis-normative definitions of masculinity, and as a result, perform a chest reconstruction 1150 
to resemble that of a cis-masculine chest. This could be construed as problematic to those who do 1151 
not identify within the binary (i.e. female or male), have different interpretations of masculinity, or 1152 
have different needs in terms of the medically necessary alleviation of incongruence. Limbs of the 1153 
 50 
questioning should address as many groups thinking about surgery as is known, with separate 1154 
pathways to answer questions as appropriate.  Third, patient samples should be racially and 1155 
ethnically diverse in order to achieve generalizability of conclusions.  This could be clarified in the 1156 
intake sign up for testing. Analysis should be independently grouped to make conclusions as 1157 
specific to an individual as possible. As the marginalization and maltreatment within healthcare 1158 
access have been reported previously, there should be a high priority not to add to previous negative 1159 
experience by any patient. Moreover, research should not further propagate the already existent 1160 
healthcare disparities for patients of color, and additionally should not forego an opportunity to 1161 
examine what effect skin color may have on the appraisal of scars (57). Ultimately, the inclusion 1162 
of a diverse patient sample could ensure more fair and equitable healthcare for patients of color. 1163 
The pursuit of gender-affirming research is necessary in order to ensure that patients are 1164 
heard appropriately and respectfully. This should allow plastic surgeons who wish to assist in their 1165 
care to strengthen the evidence-base of knowledge, cultivate important patient-provider 1166 
relationships, and ensure the highest quality of care. Given the unique nuances of conducting 1167 
research within gender-affirming healthcare, it is of paramount importance to recruit 1168 
multidisciplinary perspectives from experts in various specialties including but not limited to 1169 
primary care, endocrinology, urology, mental health and social work, and diversity and inclusion. 1170 
In addition, feedback from individuals within the transgender and gender non-conforming 1171 
communities should be integrated when designing and executing investigations. Regardless of the 1172 
criticisms and scrutiny that surround gender-affirming research, it is imperative to not retreat into 1173 
the shadows, but instead anticipate the concerns of our patients who are asked to participate, so that 1174 
we may develop stronger methodology and execution of such investigations. In doing so, we may 1175 
address concerns of the community being asked for their opinions – for the sake of our patients’ 1176 
satisfaction, understanding, and the advancement of support for them and all of us. 1177 
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Conclusion 1178 
Gender-affirming surgery has emerged as a new frontier within plastic surgery, and presents 1179 
with promising opportunities to innovate new techniques and study clinical outcomes and patient 1180 
satisfaction. Amidst such advancements, it is imperative to recognize the barriers in delivering 1181 
gender-affirming care, to collaborate with other stakeholders, and together, strengthen efforts in 1182 
medical education, policy, entrepreneurship, research, and advocacy for transgender and non-1183 
binary patients. In our current world of hope and uncertainty, there is great potential for plastic 1184 
surgeons and their colleagues to lead the movement - to best serve the social and healthcare needs 1185 
of such communities.  1186 
 1187 
References 1188 
1. Health, W. P. A. f. T. (2019). Standards of Care for the Health of Transsexual, 1189 
Transgender, and Gender- Nonconforming People. 1190 
2. Owen-Smith, A., Gerth, J, Sineanth, RC, et al.  (2018). Association Between Gender 1191 
Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, 1192 
and Mental Health in a Cohort of Transgender Individuals. J Sex Med. 15(4): 591-600. 1193 
3. Ramella, V, Papa, G, Arnez, ZM. Surgical therapy: chest wall contouring for female-to-1194 
male transsexuals. In: Trombetta, C, Liguori, G, Bertolotto, M, eds. Management of 1195 
Gender Dysphoria: A Multidisciplinary Approach. Milano, Italy: Springer; 2015: 281-1196 
287. 1197 
4. Cash T, Pruzinsky T. Body Images: Development, Deviance, And Change. New York: 1198 
Guilford Press; 1990:51-79. 1199 
5. Sarwer D, Pruzinsky T, Cash T, et al (2006). Psychological Aspects Of Reconstructive 1200 
And Cosmetic Plastic Surgery. Philadelphia: Wolters Kluwer; 37-47. 1201 
 52 
6. Berli, JU, Knudson, G, Fraser, L, Tangpricha, V, Ettner, R et al (2017). What Surgeons 1202 
Need to Know About Gender Confirmation Surgery When Providing Care for 1203 
Transgender Individuals: A Review. JAMA Surg. 152(4): 394-400.  1204 
7. Malina, S., Warbelow, S, Radix, A (2020). Two Steps Back — Rescinding Transgender 1205 
Health Protections in Risky Times. N Engl J Med. 383 (21): e116 1206 
8. El-Hadi, H., Stone, J, Temple-Oberle, C, Harrop, AR (2018). Gender-Affirming Surgery 1207 
for Transgender Individuals: Perceived Satisfaction and Barriers to Care. Plast Surg 1208 
(Oakv) 26(4): 263-268. 1209 
9. Bradford J, Reisner SL, Honnold JA, Xavier J I2013). Experiences of transgender related 1210 
discrimination and implications for health: results from the Virginia Transgender Health 1211 
Initiative Study. Am J Public Health. 103(10):1820–1829. 1212 
10. Bauer GR, Hammond R, Travers R, Kaay M, Hohenadel KM et al (2009). “I don’t think 1213 
this is theoretical; this is our lives”: how erasure impacts healthcare for transgender 1214 
people. J Assoc Nurses AIDS Care. 20(5):348–361. 1215 
11. Roberts TK, Fantz CR (2014). Barriers to quality health care for the transgender 1216 
population. Clin Biochem. 47(10-11):983–987.  1217 
12. Safer JD, Coleman E, Feldman J, et al (2016). Barriers to healthcare for transgender 1218 
individuals. Curr Opin Endocrinol Diabetes Obes.23(2):168–171. 1219 
13. Nolan, IT, Blasdel, G, Dubin, SN, Goetz, LG, Greene, RE, et al (2020). Current State of 1220 
Transgender Medical Education in the United States and Canada: Update to a Scoping 1221 
Review. J Med Educ Curric Dev. eCollection Jan-Dec 2020. 1222 
14. Click, IA, Mann, AK, Buda, M, Rahimi-Saber, A, Schultz, A, et al (2020). Transgender 1223 
health education for medical students. Clin Teach. 17(2):190-194.  1224 
 53 
15. Korpaisarn, S, Safer, JD (2018). Gaps in transgender medical education among 1225 
healthcare providers: a major barrier to care for transgender persons. Reviews in 1226 
Endocrine and Metabolic Disorders. 19: 271-275.  1227 
16. Noonan, EJ, Sawning, S, Combs, R, Weingartner, LA, Martin, LJ et al (2017). Engaging 1228 
the Transgender Community to Improve Medical Education and Prioritize Healthcare 1229 
Initiatives. Teaching and Learning in Medicine. 30:2.  1230 
17. Tollinche, LE, Walters, CB, Radix, A, Long, M, Galante, L et al (2018). The 1231 
Perioperative Care of the Transgender Patient. Anesth Analg.127 (2): 359-366. 1232 
18. Safer, JD, Tangpricha, V (2019). Care of the Transgender Patient. Ann Intern Med. 1233 
171(1):ITC1-ITC16.  1234 
19. Salibian, AA, Levitt, N, Zhao, LC, Bluebond-Langner, R et al (2018). Preoperative and 1235 
Postoperative Considerations in Gender-Affirming Surgery. Current Sexual Health 1236 
Reports. 10(4).  1237 
20. Edgerton, M, Knorr, NJ, Callison, JR (1970). The Surgical Treatment of Transexual 1238 
Patients: Limitations and Indication. Plast Reconstr Surg. 45(1): 38-46.  1239 
21. Edgerton, M (1973). Transsexualism – a surgical problem? Plast Reconstr Surg. 52(1): 1240 
74-76.  1241 
22. Edgerton, M, Sheppe, WM, Turner, UG, et al (1978). Transsexualism: An insight into the 1242 
power of psychologic gender – a panel discussion 1243 
23. Ammari T, Sluiter EC, Gast K, et al (2019). Female-to-Male Gender-Affirming Chest 1244 
Reconstruction Surgery. Aesthet Surg J. 39(2):150-163. 1245 
24. Wilson, S., Morrison, S, Anzai, L, et al (2018). Masculinizing Top Surgery: A Systematic 1246 
Review of Techniques and Outcomes. Ann Plast Surg. 80(6): 679-683. 1247 
 54 
25. Hage JJ, Bloem JJ (1995). Chest wall contouring for female-to- male transsexuals: 1248 
Amsterdam experience. Ann Plast Surg. 34(1):59-66.  1249 
26. Colić MM, Colić MM (2000). Circumareolar mastectomy in female- to-male transsexuals 1250 
and large gynecomastias: a personal approach. Aesthetic Plast Surg. 24(6):450-454.  1251 
27. Namba Y, Watanabe T, Kimata Y (2009). Mastectomy in female-to-male transsexuals. 1252 
Acta Med Okayama. 63(5):243-247.  1253 
28. Frederick MJ, Berhanu AE, Bartlett R (2017). Chest surgery in female to male 1254 
transgender individuals. Ann Plast Surg. 78(3):249-253.  1255 
29. Donato DP, Walzer NK, Rivera A, et al (2017). Female-to-male chest reconstruction: a 1256 
review of technique and outcomes. Ann Plast Surg. 79(3): 259-263.  1257 
30. McEvenue, G, Xu, FZ, Cai, R, et al (2017). Female-to-male gender affirming top surgery: 1258 
A single surgeon’s 15-year retrospective review and treatment algorithm. Aesthet Surg J. 1259 
38 (1): 49-57. 1260 
31. Cohen WA, Shah NR, Iwanicki M, et al (2019). Female-to-Male Transgender Chest 1261 
Contouring: A Systematic Review of Outcomes and Knowledge Gaps. Ann Plast Surg. 1262 
83(5):589-593. 1263 
32. Devlin, M. (2019). “Breast Augmentation Scars.” Retrieved January 16, 2021, from 1264 
https://www.drdevlin.com/blog/2019/11/12/breast-augmentation-scars-202463. 1265 
33. Gonzalez E, Frey JD, Bluebond-Langner R. Technical Refinements in Gender-Affirming 1266 
Top Surgery. Plast Reconstr Surg. 2020;146(1):38-40. 1267 
34. Lo Russo G, Tanini S, Innocenti M (2017). Masculine Chest-Wall Contouring in FtM 1268 
Transgender: A Personal Approach. Aesthetic Plast Surg41(2):369-374. 1269 
35. Berry MG, Curtis R, Davies D. Female-to-male trans- gender chest reconstruction: a 1270 
large consecutive, single-surgeon experience (2012). J Plast Reconstr Aesthet Surg. 1271 
65(6):711-719.  1272 
 55 
36. Bluebond-Langner R, Berli JU, Sabino J, et al (2017). Top surgery in transgender men: 1273 
how far can you push the envelope? Plast Reconstr Surg. 139(4):873e-882e.  1274 
37. Beer, GM, Budi, S, Seifert, B, et al (2001). Configuration and localization of the nipple-1275 
areola complex in men. Plast Reconstr Surg. 108 (7): 1947-52; discussion 1953. 1276 
38. McGregor JC, Whallett, EJ (2006). Some personal suggestions on surgery in large or 1277 
ptotic breasts for female to male transsexuals. J Plast Reconstr Aesthet Surg. 59 (8): 893-1278 
896 1279 
39. Vigneswaran, N, Lim, J, Lee, HJ, et al (2013).  A novel technique with aesthetic 1280 
considerations in female-to-male transexuals nipple areolar complex reconstruction. J 1281 
Plast Reconstr Aesthet Surg. 66 (12): 1805-1807. 1282 
40. Garber, A. (2001). Evidence-Based Coverage Policy. Health Affairs 50 (5). 1283 
41. Kozee, HB, Tylka, TL, Bauerband (2012). Measuring Transgender Individuals’ Comfort 1284 
With Gender Identity and Appearance: Development and Validation of the Transgender 1285 
Congruence Scale. Psychology of Women Quarterly.  1286 
42. Bustos, SS, Forte, AJ, Ciudad, P, Manrique, O (2020). The Nipple Split Sharing vs. 1287 
Conventional Nipple Graft Technique in Chest Wall Masculinization Surgery: Can We 1288 
Improve Patient Satisfaction and Aesthetic Outcomes? Aesthet Plast Surg. 44(5): 1478-1289 
1486.  1290 
43.  Van de Grift, TC, Kreukels, BPC, Elfering, L, Ozer, M, Bouman, MB et al (2016). Body 1291 
Image in Transmen: Multidimensional Measurement and the Effects of Mastectomy. J 1292 
Sex Med. 13(11): 1778-1786.  1293 
44. Morselli, P., Summo, V, Pinto, V, et al.  (2019). Chest Wall Masculinization in Female to 1294 
Male Transsexuals: Our Treatment Algorithm and Life Satisfaction Questionnaire. Ann 1295 
Plast Surg. 83(6): 629-635. 1296 
 56 
45. Pourdier, G., Nolan, I, Cook, T, Saia, W, Motosko, C, et al (2019). "Assessing Quality of 1297 
Life and Patient-Reported Satisfaction with Masculinizing Top Surgery: A Mixed-1298 
Methods Descriptive Survey Study." Plast Reconstr Surg, 143(1): 272-279. 1299 
46. Wanta, J., Gatherwright, J, Knackstedt, R, Long, T, Medalie, D (2019). “TRANS”-1300 
questionnaire (TRANS-Q): a novel, validated pre- and postoperative satisfaction tool in 1301 
145 patients undergoing gender confirming mastectomies. European Journal of Plastic 1302 
Surgery. 42: 527-530 1303 
47. Agarwal, C., Scheefer, MF, Wright, LN, Walzer, NK, Rivera, A (2018). Quality of life 1304 
improvement after chest wall masculinization in female-to-male transgender patients: A 1305 
prospective study using the BREAST-Q and Body Uneasiness Test. J Plast Reconstr 1306 
Aesthet Surg. 71(5): 651-657. 1307 
48. Van de Grift, TC, Elfering, L, Bouman, MB, et al (2017). Surgical indications and 1308 
outcomes of mastectomy in transmen: a prospective study of technical and self-reported 1309 
measures. Plast Reconst Surg. 140 (3): 415e-424e.  1310 
49. van de Grift TC, E. L., Greijdanus M, Smit JM, et al.  (2018). Subcutaneous mastectomy 1311 
improves satisfaction with body and psychosocial function in Trans men: findings of a 1312 
cross-sectional study using the BODY-Q chest module. Plast Reconstr Surg. 142(5): 1313 
1125-1132. 1314 
50. Klassen, A, Kaur, M, Johnson, J (2018). International phase I study protocol to develop a 1315 
patient-reported outcome measure for adolescents and adults receiving gender-affirming 1316 
treatments (the GENDER-Q). BMJ Open. 8:e025435.  1317 
51. Geerards, D., Klassen, A, Hoogbergen, M, et al.  (2019). Streamlining the Assessment of 1318 
Patient-Reported Outcomes in Weight Loss and Body Contouring Patients: Applying 1319 
Computerized Adaptive Testing to the BODY-Q. Plast Reconstr Surg 143(5): 946e-955e. 1320 
 57 
52. Klassen AF, K. M., Poulsen L, Fielding C, Geerards D, van de Grift TC, et al (2018). 1321 
Development of the BODY-Q Chest Module Evaluating Outcomes following Chest 1322 
Contouring Surgery. Plast Reconstr Surg. 142(6): 1600-1608. 1323 
53. "BODY-Q: Measuring What Matters to Patients ". from http://qportfolio.org/body-q/. 1324 
54. CDC (2020). "Adult Body Mass Index (BMI)." Retrieved October 4, 2020, from 1325 
https://www.cdc.gov/obesity/adult/defining.html. 1326 
55. “Instructions for Authors.” Plast. Reconstr Surg. 1327 
http://edmgr.ovid.com/prs/accounts/ifauth.htm 1328 
56. Belasen, A, Belasan AT. “Doctor-patient communication: a review and rationale for 1329 
using an assessment framework.” J Health Organ Manag. 2018; 8;32(7):891-907. 1330 
57.  Visscher, M., Bailer, JK, Hom, DB (2014). Scar treatment variations by skin type. Facial 1331 
Plast Surg Clin N Am. 22(3): 453-462. 1332 
58. Koh, E, Watson, DI, Dean, NR (2019). Impact of Obesity on Quality of Life After Breast 1333 
Reconstruction. Ann Plast Surg 83(6): 622-628.  1334 
59. Mehta, S, Olawoyin, O, Chouairi, F et al (2020). Worse overall health status negatively 1335 
impacts satisfaction with breast reconstruction. J Plast Reconstr Aesthet Surg 73(11): 1336 
2056-2062. 1337 
60. Mehta, S, Sheth, AH, Olawoyin, O et al (2020). Patients with psychiatric illness report 1338 
worse patient-reported outcomes and receive lower rates of autologous breast 1339 
reconstruction. Breast J 26 (10): 1931-1936.   1340 
61. Equality, N. C. f. T. (2015). US Transgender Survey. 1341 
62. Tran, BNN, Epstein, S, Singhal, D, Lee, BT, Tobias, AM, Ganor, O (2018). Gender 1342 
Affirmation Surgery: A Synopsis Using American College of Surgeons National Surgery 1343 
Quality Improvement Program and National Inpatient Sample Databases. Ann Plast Surg. 1344 
80 (4 Suppl 4): S229-S235.  1345 
63. (2020). "Solace." Retrieved December 13, 2020, from https://www.solace.lgbt. 1346 
 58 
64. (2020). "Bliss." Retrieved December 13, 3030, from https://bliss.lgbt. 1347 
65. (2020). "Clarity ". Retrieved December 13, 2020, from 1348 
https://www.kickstarter.com/projects/solacelgbt/clarity-a-solace-technology. 1349 
66. Hall, C. (2020). "Folx Health Secures $4.4M Seed To Build The New Standard For 1350 
Queer, Trans Health Care." Retrieved December 13, 2020, from 1351 
https://news.crunchbase.com/news/folx-health-secures-4-4m-seed-to-build-the-new-1352 
standard-for-queer-trans-health-care/. 1353 
67. (2020). "Plume." Retrieved December 13, 2020, from https://getplume.co. 1354 
68. (2020). "Two Fastest-Growing Trans Tech Companies, Plume and Solace, Partner to 1355 
Provide Gender-Affirming Hormone Therapy to App Users." Retrieved December 13, 1356 
2020, 2020, from https://www.prnewswire.com/news-releases/two-fastest-growing-trans-1357 
tech-companies-plume-and-solace-partner-to-provide-gender-affirming-hormone-1358 
therapy-to-app-users-301125666.html. 1359 
69. Surgeons, A. S. o. P. (2019). "Plastic Surgery Statistics Report ". 1360 
70. Nolan, I., Kuhner, C, Dy, G (2019). Demographic and temporal trends in transgender 1361 
identities and gender confirming surgery. Transl Androl Urol 8(3): 184-190. 1362 
71. Dowshen, NL, Christensen, J, Gruschow, SM (2019). Health Insurance Coverage of 1363 
Recommended Gender-Affirming Health Care Services for Transgender Youth: 1364 
Shopping Online for Coverage Information. Transgend Health. 4(1)-131-135.  1365 
72. Cohen, WA, Sangalang, AM, Dalena, MM, Ayyala, HS, Keith, JD (2019). Navigating 1366 
Insurance Policies in the United States for Gender-affirming surgery. Plast Reconstr Surg 1367 
Global Open. 7(12) – e2564.  1368 
 59 
73. Ngaage, LM, Knighton, BJ, McGlone, KL, Benzel, CA, Rada, EM et al (2019). Health 1369 
Insurance Coverage of Gender-Affirming Top Surgery in the United States. Plast 1370 
Reconstr Surg. 144(4): 824-833.  1371 
74. Canner, JK, Harfouch, O, Kodadek, LM, Pelaez, D, Coon, D et al (2018). Temporal 1372 
Trends in Gender-Affirming Surgery Among Transgender Patients in the United States. 1373 
JAMA Surg. 153(7):609-616.  1374 
75. Ngaage, LM, Knighton, BJ, Benzel, CA, McGlone, KL, Rada, EM et al (2020). A 1375 
Review of Insurance Coverage of Gender-Affirming Genital Surgery. Plast Reconstr 1376 
Surg. 145(3):803-812.  1377 
76. Lane, M, Ives, GC, Sluiter, EC, Waljee, JF, Yao, TH et al (2018). Trends in Gender-1378 
affirming Surgery in Insured Patients in the United States. Plast Reconstr Surg Global 1379 
Open. 6(4):e1738.  1380 
77. Gadkarkee, SK, DeVore, EK, Richburg, K, Lee, LN, Derakhshan, A, et al (2020). 1381 
National Variation of Insurance Coverage for Gender-Affirming Facial Feminization 1382 
Surgery. Facial Plast Surg Aesthet Med.  1383 
78. Terris-Feldman, A, Chen, A, Poudrier, G, Garcia, M (2020). How Accessible is Genital 1384 
Gender-Affirming Surgery for Transgender Patients with Commercial and Public Health 1385 
Insurance in the United States? Results of a Patient-Modeled Search for Services and a 1386 
Survey of Providers. Sex Med.8(4): 664-672.  1387 
79. Tabaac, AR, Jolly, D, Boskey, ER, Ganor, O (2020). Barriers to Gender-affirming 1388 
Surgery Consultations in a Sample of Transmasculine Patients in Boston, Mass. Plast 1389 
Reconstr Surg Global Open. 8(8): e3008.  1390 
80. Ollove, M. (2019). States Diverge on Transgender Health Care. Retrieved December 13, 1391 
2020. 1392 
81. Hart, A., Pinell-White, X, Losken, A (2016). The Psychosexual Impact of Postmastectomy 1393 
Breast Reconstruction. Ann Plast Surg. 77(5): 517-522. 1394 
 60 
82. Duggal, C., Metcalfe, D, Sackeyfio, R, Carlson, G, Losken, A (2013). Patient motivations 1395 
for choosing postmastectomy breast reconstruction. Ann Plast Surg 70(5): 574-580. 1396 
83. Bresser, P., Seynaeve, C, Van Gool, A, Brekelmans, C, Mijers-Heijboer, H, et al (2006). 1397 
"Satisfaction with prophylactic mastectomy and breast reconstruction in genetically 1398 
predisposed women." Plast Reconstr Surg. 117(6): 1675-1682. 1399 
84. (2020). Joe Biden explains how he would protect the LGBTQ community l ABC News 1400 
Town Hall. YouTube, ABC News. 1401 
85. (2020). The Biden Plan to Advance LGBTQ+ Equality in America and Around the 1402 
World. Retrieved November 7, 2020, from https://joebiden.com/lgbtq-policy/. 1403 
86. Musumeci, M., Kates, J, Dawson, L, Salganicoff, A, Sobel, L, Artiga, S (2020). Kaiser 1404 
Family Foundation. The Trump Administration’s Final Rule on Section 1557 Non-1405 
Discrimination Regulations Under the ACA and Current Status.  1406 
87. Sanger-Katz, M., Weiland, N (2020). Trump Administration Erases Transgender Civil 1407 
Rights Protections in Health Care. New York Times. 1408 
88. (2020). "THE BIDEN PLAN TO ADVANCE LGBTQ+ EQUALITY IN AMERICA 1409 
AND AROUND THE WORLD ". Retrieved December 13, 2020, from 1410 
https://joebiden.com/lgbtq-policy/. 1411 
89. Strouma, D., Kirkland, AR (2020). Health Coverage and Care for Transgender People - 1412 
Threats and Opportunities. N Engl J Med 383: 2397-2399. 1413 
90. Herman, J., O’Neill, K (2020). Vulnerabilities to COVID-19 Among Transgender Adults 1414 
in the U.S., UCLA School of Law Williams Institute. 1415 
91. Sarac, B., Schoenbrunner, A, Wilson, S, Chiu, E, Janis, J (2020). The Impact of COVID-1416 
19-based Suspension of Surgeries on Plastic Surgery Practices: A Survey of ACAPS 1417 
Members. Plast Reconstr Surg Glob Open 8(8): e3119. 1418 
 61 
92. van der Miesen, A., Raaijmakers, D, van de Grift, T (2020). You Have to Wait a Little 1419 
Longer”: Transgender (Mental) Health at Risk as a Consequence of Deferring Gender-1420 
Affirming Treatments During COVID-19. Arch Sex Behav: 1-5 1421 
93. "CDC Social Vulnerability Index." Retrieved December 13, 2020, from 1422 
https://www.atsdr.cdc.gov/placeandhealth/svi/index.html. 1423 
94. Surgeons, A. C. o. "What are the surgical specialties." Retrieved October 1, 2020, from 1424 
https://www.facs.org/education/resources/medical-students/faq/specialties. 1425 
95. Cigna (2020). "Medical Necessity Definitions." Retrieved October 4, 2020. 1426 
96. (2020). "Medically Necessary ". Retrieved October 4, 2020, from 1427 
https://www.healthcare.gov/glossary/medically-necessary/. 1428 
 1429 
Figure and Table Legends 1430 
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Video 2: Intraoperative technique 1439 
Figure 4. Re-approximating the axilla using the 7cm markings  1440 
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A is at a point 5mm-1cm behind the pectoralis where the pectoralis meets the anterior axillary line. 1442 
B represents the pivot point 7cm posterolateral from A.  B is joined to meet D which is located on 1443 
the anterior axillary line. E represents the most medial point of the double incision, and both the 1444 
superior and inferior incisions are brought to meet the anterior axillary line at D. a. C is a point on 1445 
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the line BD that is 7cm inferior from B. C is rotated upward to meet A. b. The midclavicular line 1446 
on the superior flap is brought laterally to avoid dog ears medially. c. Excess tissue at point D is 1447 
removed, which equalizes the length of the superior and inferior flaps, as well as ensures a scar that 1448 
slopes upwards along the outline of the pectoralis muscle. d. Final closure of the incision shows 1449 
the segment A(C)-B is hidden in the axillary fold.   1450 
Figure 5. Shifting of the midline of the superior incision  1451 
 1452 
The blue dotted lines represent the midclavicular line marked at the beginning of surgery. In closing 1453 
the incision, the point at the midclavicular line on the superior flap is reconnected to the inferior 1454 
flap about 2cm lateral to the midclavicular line. Because of the contour of the breast, the inferior 1455 
incision is shorter in length than the superior incision, and this shift reduces the length discrepancy 1456 
of excess that remains on the superior flap. 1457 
Figure 6. Pre- and post-op photos of a patient who underwent the hockey stick procedure 1458 
 1459 
Pre- and post-op photographs of a patient with BMI 26.55. a, b, and c demonstrate pre-op photos 1460 
from the front, lateral, and 45 degrees lateral view, respectively. d shows the final result at 2 months 1461 
from the anterior view. e shows demonstrates axillary extension which is hidden in the axillary 1462 
crease. f shows a 2-week post-op photo from the 45 degrees lateral view, where the outline of the 1463 
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Figure 7. Comparison of operative details across incision types 1472 
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The peri-areolar incision group is significantly different from the inframammary fold and hockey 1474 
stick incision groups in terms of volume of liposuction, operative time, and amount of tissue 1475 
removed. No other significant differences are found between the remaining groups.  1476 
Figure 8. Weeks to any activity by individual patients undergoing various incision types  1477 
 1478 
Each dot represents an individual patient, while the horizontal bars represent the mean recovery 1479 
time of each group. The time to resuming activity is lowest for those who most recently 1480 
underwent the hockey stick incision, although statistical significance was not observed. 1481 
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